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CHAPTER I 
 
INTRODUCTION 
 
An Introduction to p120-catenin 
 p120-catenin (hereafter p120) was originally identified as a highly tyrosine-
phosphorylated protein in src-transformed chick embryo fibroblasts (Reynolds et al., 
1989). p120 is the prototypical member of a family of armadillo-repeat proteins that 
includes -catenin, ARVCF, p0071, and plakophilins (Anastasiadis and Reynolds, 2000). 
p120 was later identified as a catenin that interacts with and stabilizes classical cadherins 
such as E-cadherin and N-cadherin (Davis et al., 2003; Ireton et al., 2002; Reynolds et al., 
1994). Cadherins mediate cell-cell adhesion through homophilic interactions between 
adjacent cells (Takeichi, 1995). By regulating cadherin stability, p120 is an important 
regulator of cell-cell adhesion and tissue morphogenesis. p120 can also localize to the 
cytoplasm and nucleus, where its functions remain unclear. Recent studies, described 
below, have demonstrated that p120 also participates in a number of signaling pathways 
that are frequently altered in cancer including tyrosine kinase signaling, Rho GTPase 
signaling, transcriptional regulation, and Wnt signaling (Figure 1). Furthermore, 
downregulation and/or mis-localization of p120 has been detected  in a number of 
cancers and often correlates with poor prognosis (van Hengel and Van Roy, 2007). Thus, 
p120 may serve as a tumor suppressor. 
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Figure 1: Localization and functions of p120. In epithelial cells, p120 is primarily 
localized to the cell membrane, where it binds to and stabilizes E-cadherin. p120 is also 
found in the cytoplasm where it may regulate Rho GTPases, and in the nucleus where its 
function remains unknown. p120 has also been implicated in Wnt signaling, which also 
involves -catenin in a cadherin-independent signaling function. 
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Structure of p120-catenin 
Among the most prominent features of p120 is a central armadillo-repeat domain. 
p120 has 9 42 amino acid armadillo repeats, with arm repeats 1-7 required for the 
interaction with classical cadherins (Ireton et al., 2002). The armadillo domain is  
flanked by the N-terminal regulatory domain and the C-terminal tail (Figure 2). The 
regulatory domain is extensively phosphorylated on tyrosine, serine, and threonine 
residues and features a 100 amino acid coiled-coil domain on the extreme N-terminus. 
The N-terminal regulatory domain can regulate p120’s adhesive functions through a 
mechanism that may involve phosphorylation of the N-terminus (Aono et al., 1999). The 
C-terminal tail of p120 is relatively poorly understood, but does contain 3 known 
phosphorylation sites and has been implicated in cadherin trafficking (Liu et al., 2007).  
The N-terminus of p120 contains four in-frame start codons, resulting in four 
possible p120 isoforms, designated isoforms 1-4 (Figure 2) (Keirsebilck et al., 1998). 
Isoform 1 encodes the full-length p120 protein, while isoforms 2-4 produce progressively 
truncated proteins, with isoform 4 lacking the entire N-terminus. Isoform 1 is expressed 
primarily in mesenchymal and motile cells such as fibroblasts, whereas isoform 3 is the 
predominant p120 isoform in epithelial cells (Mo and Reynolds, 1996). Isoform one 
appears to preferentially interact with mesenchymal cadherins (e.g. N-cadherin) while 
isoform 3 preferentially binds E-cadherin (Seidel et al., 2004). Isoform 4 is rarely 
observed at the protein level, but has been detected at the mRNA level. Interestingly, 
when expressed exogenously, isoform 4 can stabilize E-cadherin more efficiently than 
other p120 isoforms presumably because it is not subject to regulation via the N-terminus 
(Aono et al., 1999; Ireton et al., 2002). 
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Figure 2: Structure of p120 isoforms. The schematic structure of full-length p120 
1ABC and isoforms 3 and 4 are shown. Alternatively spliced exons (A, B, C) are 
indicated by blue boxes. Serine/threonine and tyrosine phosphorylation sites are indicated 
black and red balloons, respectively.  
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In addition to alternative start codons, p120 features 3 alternatively spliced exons, 
designated as exons A, B, and C. The role of these alternatively spliced exons remain 
unclear; however, exon B does contain a functional nuclear export signal (NES) (van 
Hengel et al., 1999). Thus it appears that p120 isoforms and exons may determine the 
specific function of a given p120 molecule; however, current reagents and assays have 
been unable to precisely determine the functional significance of p120 isoforms. It is  
worth noting that in the vast majority of studies in which p120 is exogenously expressed, 
only exon A is included. Thus, any functions associated with exons B and C have been 
excluded from these studies.  
 
Phosphorylation of p120 
 The N-terminal regulatory domain and C-terminal tail of p120 contains ten 
tyrosine and eight serine/threonine phosphorylation sites that are regulated by a variety of 
signaling pathways (Figure 3). All of the tyrosine phosphorylation sites identified (Figure 
2) can be phosphorylated by oncogenic src (Luo et al., 2008; Mariner, 2001; Mariner et 
al., 2001); however, other kinases including EGFR (Mariner et al., 2004), Fyn (Castaño 
et al., 2007), and Fer (Lee, 2005) have also been implicated in tyrosine phosphorylation 
of p120. Tyrosine phosphorylation appears to affect the ability of p120 to bind to 
cadherins (Ozawa and Ohkubo, 2001), providing a potential mechanism by which 
tyrosine kinases can destabilize cell-cell adhesion. However, simultaneous mutation of 
eight tyrosines to phenylalanine revealed no defects with regards to cell-cell adhesion and 
the actin cytoskeleton (Mariner et al., 2001). This suggests that tyrosine phosphorylation 
is  
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Figure 3: Reported mechanisms of p120 phosphorylation. PKC activation by PMA 
or other stimuli induces dephosphorylation of the N-terminus of p120, and 
phosphorylation of S879 on the C-terminus. CK1 can phosphorylate S268 and S279 in 
tandem. Src can phosphorylate each of the identified tyrosine phosphorylation sites. Fer, 
EGFR, and Fyn have also been implicated. 
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dispensable for the adhesive functions of p120, but may be involved in cadherin-
independent functions. 
The mechanisms governing serine/threonine phosphorylation of p120 remain 
unclear. Activation of PKC, specifically PKC, causes dephosphorylation of 
serine/threonine residues within the regulatory domain and promotes the phosphorylation 
of serine 879 on the C-terminal tail (Brown et al., 2009; Xia et al., 2006; Xia et al., 2003). 
However, the phosphatases and kinases that act on p120 downstream of PKC remain 
unknown. Recent evidence indicates that serines 268 and 288 can be phosphorylated by 
CK1 (Casagolda et al., 2010) and PAK5 (Wong et al., 2010), respectively. To date, few 
specific functions have been associated with p120 phosphorylation, and those that have 
been identified appear to depend on specific cellular contexts. As with the tyrosine 
residues, simultaneous mutation of all the serine/threonine phosphorylation sites to 
alanine did not induce any cell-cell adhesion or cytoskeletal defects in cells (Xia et al., 
2006). Thus, the mechanisms and functional significance of p120 phosphorylation 
remains an area of active investigation. 
 
 
An Introduction to the Cadherin Complex 
 
 
The structure and function of the cadherin complex 
Classical cadherins are single-pass transmembrane proteins that form homotypic 
interactions in trans with cadherins on adjacent cells to mediate cell-cell adhesion 
(Takeichi and Abe, 2005). Homophilic interactions are mediated by the extracellular 
8 
domain of cadherins in a calcium-dependant manner, adhesion is further strengthened by 
the lateral clustering of cadherin molecules, which is mediated in part by homophilic cis 
interactions between adjacent cadherins on the cell surface (Ozawa, 2002; Shan et al., 
2000) in addition to interactions with the underlying actin cytoskeleton. This lateral 
clustering of cadherins at cell surface combined with the formation of adhesive trans-
dimers between cadherins adjacent cells results in the formation of the adherens junction 
(AJ) (Figure 4). 
Cadherins feature a large extracellular domain and a small cytoplasmic tail that 
interacts with catenins. In this cytoplasmic tail, p120 binds to the highly conserved Juxta-
Membrane Domain (JMD) (Thoreson et al., 2000) while -catenin and Plakoglobin bind 
to the C-terminal Catenin Binding Domain (CBD) (Gumbiner, 2005; Stappert and 
Kemler, 1994). -catenin and/or Plakoglobin directly bind to -catenin, which 
physically/and or functionally links cadherins to the actin-cytoskeleton (Rimm et al., 
1995; Yamada and Nelson, 2007). E-cadherin (or another classical cadherin), p120, -
catenin, and -catenin represent the core components of the cadherin complex, although 
many other proteins are known to associate with the complex to regulate adhesive 
strength, cadherin turnover, and downstream signaling events. 
In addition to their structural role, cadherins participate in a number of cancer-
relevant cell signaling pathways including receptor and non-receptor tyrosine kinase 
signaling (Pece et al., 2000; Calautti et al., 1998; McLachlan et al., 2007), activation of 
Rho family GTPases (Calautti et al., 2002; Fukuyama et al., 2006; Pece and Gutkind, 
2000), and PI3K signaling (Woodfield et al., 2001). These mechanisms largely involve  
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Figure 4: Schematic of the adherens junction. The core components of the cadherin 
complex are shown on each cadherin molecule. To show the catenins, the cytoplasmic 
tail of E-cadherin is enlarged relative to the extracellular domain in this schematic. Each 
cadherin is functionally linked to the F-actin cytoskeleton by -catenin. 
 
10 
the recruitment of signaling molecules to the cadherin complex. For example, E-cadherin 
can physically interact with EGFR via the cadherin’s extracellular domain and/or the 
cytoplasmic adaptor protein Merlin (Curto et al., 2007), and this interaction can inhibit 
ligand-dependent RTK signaling in confluent cells (Qian et al., 2004). Conversely, 
cadherin clustering has can activate EGFR in a ligand-independent manner by co-
clustering of the receptor with cadherins. 
 
E-cadherin status and cancer progression 
 As a tumor transitions to malignancy, tumor cells escape from the primary tumor 
to secondary sites of metastasis (Hanahan and Weinberg, 2000). This often involves 
individual cells detaching from adjacent cells and migrating away from the tumor, a 
process that involves the loss of cell-cell adhesion (Yilmaz and Christofori, 2010). 
Consistent with this, loss of E-cadherin has been observed as tumors progress to 
malignancy (Birchmeier and Behrens, 1994). The transition of epithelial cells from a 
sessile phenotype associated with normal tissue to a motile phenotype associated with 
malignancy is known as Epithelial-to-Mesenchymal Transition (EMT) (Micalizzi et al., 
2010). EMT is characterized by a number of physical and genetic changes in cell 
adhesion and cellular signaling. One hallmark of EMT is the downregulation of E-
cadherin and upregulation of N-cadherin (or other mesenchymal cadherins) via the 
transcription factors Snail and Slug (Batlle et al., 2000; Cano et al., 2000). Interestingly, 
this tumor progression is accompanied by altered p120 localization and/or switching of 
p120 isoforms from 1 to 3 (Bellovin et al., 2005; Sarrió et al., 2004). E-cadherin can also 
suppress tumorigenesis via sequestration of -catenin at the membrane, thereby 
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suppressing Wnt signaling, which is frequently up-regulated in cancer (Gordon and 
Nusse, 2006).  
 
Regulation of Cadherin Stability by p120 
 
Physical Interaction between p120 and E-cadherin 
 p120 directly interacts with E-cadherin (and other classical cadherins) via the 
highly conserved Juxta-Membrane Domain (JMD) of the cadherin’s cytoplasmic tail 
(Thoreson et al., 2000). A triple-alanine mutation within the JMD can effectively 
uncouple p120 from E-cadherin without affecting -catenin binding and results in 
significantly weaker cell-cell adhesion. Conversely, p120 interacts with E-cadherin via its 
central armadillo-repeat domain, particularly arm repeats 1-5 (Ireton et al., 2002; 
Ishiyama et al., 2010). Deletion of any of these individual repeats produces a p120 that 
cannot stabilize cadherins.  
Recently the crystal structure of the JMD in complex with p120 4A has been 
resolved, revealing key molecular details of the p120-E-cadhering interaction (Ishiyama 
et al., 2010). p120 features a basic arm that binds to the JMD within an N-terminal acidic 
region via several salt bridges and a triple-glycine motif. Residues K401 and K444 of 
p120 form salt bridges with the acidic region of the JMD, while N478 interacts with the 
triple-glycine motif of the JMD. Mutation of any one of these 3 amino acids in p120 can 
uncouple p120 from E-cadherin. In addition to the basic arm, p120 also has a 
hydrophobic pocket in which a C-terminal “anchor region” of the JMD rests. 
Interestingly, these binding sites on the JMD all correspond precisely with the triple-
12 
alanine mutations of E-cadherin, which our lab had previously demonstrated to uncouple 
p120 and E-cadherin (Thoreson et al., 2000).  
 
Stabilization of E-cadherin by p120 
 Given the association of p120 with E-cadherin and the dramatic disruption of cell-
cell adhesion in src-transformed cells, it was hypothesized that p120 played an important 
role in regulating the cadherin complex. Using the p120-deficient SW48 cell line, it was 
demonstrated that p120 expression promoted E-cadherin stability. p120 expression did 
not upregulate E-cadherin mRNA levels, but did approximately double the half-life of E-
cadherin protein (Ireton et al., 2002). Depletion of endogenous p120 in multiple cell lines 
using shRNA further confirmed these results, and indicated that in the absence of p120, 
cell-surface E-cadherin is rapidly internalized and degraded (Davis et al., 2003). These 
data are supported by structural analysis of the p120-JMD interaction. When bound to E-
cadherins, p120 masks a dileucine motif within the JMD which, when unmasked, 
promotes internalization of E-cadherin (Ishiyama et al., 2010; Miranda et al., 2001; 
Miyashita and Ozawa, 2007). While p120-family members such as ARVCF can 
functionally substitute for p120, they are rarely expressed in most tissue, particularly in 
epithelial cells (Mariner et al., 2000). Thus, in most cell types, loss of p120 leads to loss 
of cadherins and cell-cell adhesion, a hallmark of metastatic cancer progression.  
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Rho GTPase signaling and p160 Rho Kinase 
 
Rho Family GTPases  
 Rho (Ras Homologous) Family GTPases are members of the Ras superfamily of 
small proteins that function as binary switches in response to stimuli. In addition to the 
Rho family, the Ras superfamily includes the Ras, Ran, Rab, and Arf families of 
GTPases. Rho family proteins are distinguished from other Ras-related proteins by the 
presence of a Rho insert domain within the GTPase domain, which is involved in the 
activation of downstream effectors (Valencia et al., 1991). The Rho family of GTPases is 
itself divided into several groups, including the Rho proteins (RhoA, RhoB, and RhoC), 
the Rac proteins (Rac1, Rac2, Rac3, and RhoG), the Cdc42-like proteins (cdc42, TC10, 
TCL, Wrch1, Chp), the Rnd proteins (Rnd1, Rnd2, and Rnd3/RhoE), the RhoBTB 
proteins (RhoBTB1, RhoBTB2, RhoBTB3), and the Miro proteins (Miro1, Miro2) (Grise 
et al., 2009). In particular RhoA and Rac1 have been functionally linked to p120 and 
cadherin function.  
Rho GTPases exist in either an active conformation with GTP bound or in an 
inactive conformation with GDP bound. In the active GTP-bound state, the GTPase can 
bind to effector proteins to initiate downstream signaling events (Jaffe and Hall, 2005) 
(Figure 5). Activation of GTPases is catalyzed by Guanine Exchange Factors (GEFs) that 
promote the release of bound GDP and subsequent GTP binding, inducing a 
conformational change that permits effector binding and downstream signaling (Schmidt 
and Hall, 2002). Inactivation occurs when the GTPase hydrolyzes GTP to GDP, 
catalyzed by GTPase Activating Proteins (GAPs), switching the GTPase back to the  
14 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Regulation of Rho GTPases. A schematic illustrating the mechanisms of 
RhoA regulation. RhoA is activated by GEFs (e.g. p115 RhoGEF), and activated RhoA 
can then activate downstream effector proteins. RhoA activity is suppressed by GAPs 
(e.g. p190 RhoGAP). GDP-bound Rho is maintained in the inactive state by GDIs (e.g. 
RhoGDI) that sequester Rho in the cytoplasm and prevent membrane anchoring.  
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inactive state and causing dissociation of effector proteins (Bernards, 2003). GTPase 
signaling can also be suppressed by Guanine Dissociation Inhibitors (GDIs), which bind 
to GDP-bound GTPases and sequester them from GEFs and effector proteins (Olofsson, 
1999). Binding to a GDI also protects GTPases from proteosomal degradation (Boulter et 
al., 2010). Typically, active GTPases are localized to the cell membrane by a C-terminal 
CAAX motif while inactive GTPases are found in the cytoplasm. 
 
RhoA and Rac1 Signaling 
The RhoA and Rac1 GTPases are among the most well characterized members of 
the Rho family of GTPases. These GTPases play an important role in the regulation of 
the actin cytoskeleton downstream of adhesion and receptor-mediated signaling during 
diverse processes such as motility, adhesion, and cell growth (Burridge and Wennerberg, 
2004). RhoA promotes contractility through its effector proteins such as Rho Kinase, 
which activates Myosin, and LIMK, which inhibits cofilin to promote the assembly of 
actin stress fibers. Rac1 activation leads to pronounced cell spreading, membrane 
ruffling, and migration in part through activation of the PAK family of serine/threonine 
kinases (Hall, 2005). However, both RhoA and Rac1 are also involved in the formation 
of adhesion complexes (both focal adhesions and adherens junctions) (Braga et al., 1997; 
Hotchin and Hall, 1995), protein trafficking (Garnacho et al., 2008; Matas et al., 2005), 
transcriptional regulation, and proliferation (Hall, 2005).  
Balance between RhoA and Rac1 activities is maintained, in part, by the 
antagonistic relationship between the two GTPases. Specifically, activation of Rac1 leads 
to the generation of Reactive Oxygen Species and the downstream activation of p190 
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RhoGAP, a Rho-specific GAP, leading to the suppression of RhoA signaling (Nimnual et 
al., 2003). In epithelial cells, this antagonism is particularly important for the 
maintenance of proper cell morphology and is disrupted in transformed cells (Zondag et 
al., 2000). Previous work from our lab has demonstrated that p120 plays a role in this 
pathway of Rac-mediated  inhibition of RhoA by recruiting p190 RhoGAP to the 
cadherin complex (Wildenberg et al., 2006). On the other hand, RhoA can inhibit Rac1 
activity through Rho Kinase (Tsuji et al., 2002; Yamaguchi et al., 2001), although the 
precise mechanisms remain unclear. 
 
Rho Kinases 
 A major function of RhoA is to promote acto-myosin contractility, which is 
accomplished in part through activation of Rho Kinase (ROCK). Rho Kinase, the first 
identified effector of RhoA, is a serine/threonine kinase that is related to myotonic 
dystrophy kinase (DMPK), DMPK-related cdc42 binding kinase (MRCK), and citron 
kinase (Riento and Ridley, 2003). Two isoforms of ROCK exist; p160 Rho 
Kinase/ROCK1/ROK and ROCK2/ROK. The two isoforms share 65% overall 
sequence identity, and 92% similarity within their kinase domains (Nakagawa et al., 
1996) (Figure 6a). Both isoforms are expressed ubiquitously, although the relative 
expression levels of ROCK1 and ROCK2 vary among different tissues. ROCK1 is the 
predominate isoform in the liver, spleen, and kidney, while ROCK2 is expression is 
highest in muscle and brain tissue. There are a number of redundant functions shared 
between ROCK1 and ROCK2, but a number of isoform-specific functions have been  
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Figure 6: Isoforms and regulation of p160 Rho Kinases. (a) A schematic of ROCK1 
and ROCK2. The region between the kinase domain and the Pleckstrin Homology (PH) 
domain, including the Rho Binding Domain (RBD) is predicted to form a coiled-coil. The 
PH domain also contains a Cysteine Rich Domain (CRD). (b) Schematic for activation of 
ROCK. In the inactive state, the C-terminus of ROCK is folded over to mask the kinase 
domain. Rho binding induces a conformational change that unmasks the kinase domain. 
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identified (Lock and Hotchin, 2009). In particular, ROCK2 plays a role in the 
disassembly of epithelial apical junctions (Samarin et al., 2007). Rho kinases are 
activated by RhoA binding, which induces a conformational change that unmasks the 
kinase domain of ROCK, allowing it to phosphorylate its substrates (Figure 6b). 
The major substrates of ROCK are proteins that regulate acto-myosin 
contractility. ROCK can promote myosin activity by directly phosphorylating the 
regulatory light chain of myosin II on serine 19 (Amano et al., 1996; Totsukawa et al., 
2000), which stimulates the ATPase activity of Myosin (Somlyo and Somlyo, 2000). 
Alternatively, ROCK1 can indirectly promote myosin activity by phosphorylating and 
thereby inhibiting Myosin Phosphatase. Myosin Phosphatase is responsible for 
dephosphorylating serine 19 of myosin light chain, thereby suppressing the motor activity 
(Kawano et al., 1999; Kimura et al., 1996). In addition to the myosin pathway, ROCK 
can phosphorylate LIM-Kinase (LIMK), which in-turn phosphorylates and inhibits the 
actin-severing protein cofilin (Maekawa et al., 1999). This results in the stabilization of 
actin cables, another requirement for contractility. Thus, cellular processes that require 
acto-myosin contractility such as motility, adhesion, and polarity, are all dependent on 
ROCK activity.  
 Rho Kinases phosphorylate a number of additional substrates besides Myosin and 
LIMK. ROCK can phosphorylate and activate Ezrin/Radixin/Moesin (ERM) proteins, a 
family of proteins that crosslink actin filaments and membrane proteins and are involved 
in epithelial polarity and migration (Matsui et al., 1998; McClatchey and Fehon, 2009). 
ROCK can also regulate the formation of intermediate filaments by phosphorylating 
vimentin, glial fibrillary acid protein (GFAP), and nuerofilament L protein (NF-L), 
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leading to disassembly of intermediate filaments (Goto et al., 1998; Hashimoto et al., 
1998; Kosako et al., 1997). ROCK1 can also phosphorylate the translation co-factor 
Elongation Factor 1 (EF-1), which also functions as an actin bundling protein (Izawa et 
al., 2000). 
 
RhoA and Rho Kinases in cancer 
 Given their importance in regulating the actin cytoskeleton, adhesion, and 
motility, it is not surprising that RhoA and ROCK have been implicated in cancer 
progression. RhoA is required for transformation by oncogenic Ras (Qiu et al., 1995), 
indicating that cross-talk between GTPases plays an important role in cancer progression. 
Furthermore, increased RhoA expression has been detected in a number of epithelial 
cancers (Ellenbroek and Collard, 2007). Unlike Ras, which is frequently mutated in 
cancer, no mutations in RhoA have been detected in human cancers. It appears that 
mutation of Rho proteins is not tolerated, however mutation of regulatory and effector 
proteins have been detected in cancers.  
Recently, 3 unique activating mutations in ROCK1 have been identified in 
malignant human cancers (Lochhead et al., 2010). In addition, elevated levels of ROCK1 
and ROCK2 have been detected in late-stage testicular cancer (Kamai et al., 2004). 
Furthermore, ROCK1 expression was found to be significantly higher in human 
mammary tumors, and both ROCK isoforms contributed to breast cancer cell invasion 
(Lane et al., 2008). Interestingly, ROCK activity is suppressed in Ras-transformed cells, 
and over-expression of ROCK can reverse morphological transformation (Izawa et al., 
1998), suggesting that inhibition of ROCK signaling is required for tumorigenicity. In our 
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own studies, p120 loss in v-src and Rac-transformed MDCK cells blocks growth in soft 
agar, and growth can be rescued ROCK inhibition using Y-27632 (Dohn et al., 2009). 
Thus p120 appears to be directly involved in the suppression of ROCK1 in transformed 
cells.  
 
Regulation of Rho GTPases by p120 
Over-expression of p120 using CMV-driven expression vectors led to dramatic 
alterations in cell morphology, suggesting that p120 regulates the actin cytoskeleton. 
Initial studies suggested that p120 behaved as a RhoGDI (Anastasiadis et al., 2000), 
directly binding and sequestering RhoA. In Drosophila melanogaster, a p120 homolog 
can directly bind Rho1 (Magie and Parkhurst, 2002), supporting a GDI-like function. 
However, further study revealed that the Drosophila p120 homolog might be distinct 
from mammalian p120 with respect to cell-cell adhesions and Rho function (Fox, 2005; 
Myster, 2003).  Recent studies in mammalian cells have identified potential binding sites 
for a direct p120-RhoA interaction, Y112 and amino acids 622-8 (Castaño et al., 2007; 
Yanagisawa et al., 2008). p120 can also suppress RhoA indirectly by recruiting p190-
RhoGAP to the cadherin complex (Wildenberg et al., 2006), suggesting that there are 
multiple mechanisms by which p120 can suppress RhoA activity.  
While the majority of work has focused on the relationship between p120 and 
RhoA, recent evidence points to an equally important relationship with Rac1. Early 
studies indicated p120 over-expression leads to activation of Rac1 by Vav2 (Noren et al., 
2000). In addition, cadherin-dependent activation of Rac1 requires the binding of p120 to 
E-cadherin (Goodwin et al., 2003). Similarly to its interaction with RhoA, p120 can 
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physically interact with Rac1b (Orlichenko et al., 2010), a constitutively active splice-
variant or Rac1 found in tumor cells (Matos, 2003). This interaction appears to involve 
the same residues of p120 that mediate the p120-RhoA interaction, suggesting that p120 
regulates Rac1b using a similar mechanism as RhoA. Furthermore, activation of Rac1 by 
p120 is essential for the growth and survival of tumor cells through a mechanism 
involving the Ras/Mek/ERK pathway (Soto et al., 2008). However in non-tumorigenic 
cells, p120 suppresses Rac1 signaling, thereby suppressing growth. These data indicate 
that p120 can affect Rac1 signaling differently depending on cellular context. In highly 
motile cells (e.g. fibroblasts and metastatic cancer cells), p120 promotes Rac1 activity 
and cell survival, possibly through stabilization of mesenchymal cadherins (Yanagisawa 
and Anastasiadis, 2006). On the other hand, in normal epithelial cells, p120 suppresses 
Rac1 signaling and cell growth, in part through stabilization of E-cadherin.  
 p120’s physical and functional interaction with both RhoA and Rac1 is 
particularly interesting because of the antagonistic relationship between the two small 
GTPases. In NIH-3T3 cells, Rac1-mediated inhibition of RhoA requires p120 to recruit 
p190 RhoGAP to the cadherin complex. This process appears to be required in contact 
inhibition of cell growth in NIH-3T3 cells. Presumably, this pathway is intact in Rac-
transformed MDCK cells grown in soft agar, since p120 is required to suppress RhoA 
and support anchorage independent growth (AIG) (Dohn et al., 2009). Thus p120 appears 
to be important for the cross-talk between Rac1 and RhoA, keeping the activities of each 
GTPase in check. 
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p120 Binding Partners 
 p120 primarily interacts with classical cadherins, but recent work has 
demonstrated that p120 can interact with a variety of proteins and complexes. However,  
by analogy to -catenin, a structurally and functionally similar protein, relatively few 
p120 binding partners have been characterized (Figure 7). Importantly, many of these -
catenin binding partners, identified through protein-protein interaction screens, mediate 
the cadherin-independent Wnt signaling functions of -catenin, which play an important 
role in cancer progression. A comprehensive list of binding partners is provided in Table 
1. In particular, p120 interacts with kinases and phosphatases, RhoA regulatory 
complexes, and with transcriptional regulators.  
 
Interactions with Kinases and Phosphatases 
 p120 can associate with a number of kinases and phosphatases. In particular, p120 
has been shown to interact with a number of tyrosine phosphatases including SHP-1 
(Keilhack et al., 2000), RPTPμ (Zondag et al., 2000), and DEP1 (Holsinger et al., 2002). 
p120 can also interact with the src-family kinase Fyn and the non-src family tyrosine 
kinase Fer (Piedra et al., 2003). Phosphorylation of p120 by Fyn appears to regulate 
binding of RhoA (Castano et al., 2007). However, no specific physiological function has 
been assigned to the other interactions between p120 and tyrosine kinases and 
phosphatases, although it has been proposed that modulation of p120 phosphorylation by 
kinases and phosphatases regulates p120’s association with cadherins (Ozawa et al., 
2001, Aono et al., 1999), and thereby regulates cadherin stability and cell-cell adhesion.  
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Figure 7: A schematic comparison of known -catenin and p120 partners. 
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Table 1: Reported binding partners of p120. When available, the reported binding site 
on p120 is provided for each protein. N/A indicates no binding site has been identified. 
Binding Partner Binding Site 
(p120) 
Proposed Function of the 
Interaction 
 
Reference 
Kaiso ARMs 1-6 Transcriptional Regulation Daniel and 
Reynolds, 1999 
MUC1 N/A Promotes p120 nuclear localization Li and Kufe, 2001 
Kinesin N-terminus Cadherin transport/recycling Chen et al., 2003 
p190 RhoGAP N/A Rho Inhibition and Contact 
Inhibition 
Wildenberg et al., 
2006 
RhoA N-terminus & 
622-628 
Rho Inhibition (GDI-like 
mechanism) 
Anastasiadis et al., 
2000 
Rac1b N-terminus 
& 622-628 
Directed cell migration Orlichenko et al., 
2010 
Cortactin N/A Lamellopdial dynamics Boguslavsky et al., 
2007 
Fer N/A Tyrosine phosphorylates p120, 
suppresses neurite branching 
Lee et al., 2005 
Fyn N/A Tyrosine phosphorylates p120 
(Y112), regulates RhoA binding 
Piedra et al., 2003 
DEP1 N/A Dephosphorylation of p120 Holsinger et al., 
2002 
SHP1 N/A Dephosphorylation of p120 Keilhack et al., 2000 
RPTPμ N-terminus Dephosphorylation of p120 Zondag et al., 2000 
Glis2 N/A Transcriptional Regulation Hosking et al., 2007 
-secretase N/A Receptor proteolysis Kiss et al., 2008 
Frodo N/A Stabilizes p120 in response to Wnt 
signaling 
Park et al., 2006 
Nanos-1 N/A Suppression of Rho inhibition Strumane et al., 2006 
Cdk2 N/A Cell cycle regulation Chartier et al., 2007 
Desmoglein 3 N/A Desmosome assembly Kanno et al., 2008 
CagA N/A Suppresses p120 phosphorylation 
and cell-invasive phenotype 
Oliviera et al., 2009 
PLEKHA7 N-terminus Anchorage of microtubules to the 
adherens junction 
Meng et al., 2008 
Pak5 N/A Phosphorylates p120 on S288 Wong et al., 2010 
Casein Kinase 1 
(CK1) 
N/A Phosphorylation Serine 268 and 
269, mediates a role in Wnt 
signaling 
Casagolda et al., 
2010 
GSK-3 N-terminus Mediates degradation of p120 by the 
APC destruction complex 
Hong et al., 2010 
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 Although p120 is extensively phosphorylated on serine and threonine, no 
phosphatases that bind and act on p120 have been identified. Recently, two 
serine/threonine kinases have been identified to interact with p120. Casein Kinase 1 
(CK1) binds and phosphorylates p120 on S268 following Wnt stimulation in SW480 
cells (Casagolda et al., 2010). In this system, p120 is required for the formation of the 
Wnt signalasome and subsequent -catenin activation. The Rac/cdc42 effector PAK5 can 
bind to p120 and phosphorylate it on S288 (Wong et al., 2010), suggesting that effector 
of Rho GTPases can signal to p120. p120 may also associate with GSK3 within the 
destruction complex to regulate p120 levels in a manner similar to -catenin (Hong et al., 
2010). Future studies using phospho-specific p120 antibodies could identify the kinases 
and phosphatases that directly bind and regulate p120, and elucidate the function of these 
phosphorylation events.  
 
Interactions with Rho Proteins 
 As discussed above, p120 plays an important role in the regulation of Rho 
GTPases through interactions with the Rho proteins themselves as well as with Rho 
regulatory proteins. p120 can directly bind to both RhoA (Castano et al., 2007) and 
Rac1b (Orlichenko et al., 2010), a constitutively active splice variant of Rac1. In both 
cases, this interaction is mediated by phosphorylation of Y112 on the N-terminus and 
amino acids 622-8. p120 also interacts with p190 RhoGAP to localize Rho suppression to 
the cadherin complex (Wildenberg et al., 2006). In addition, the zinc-finger protein 
Nanos1 regulates RhoA activity. Nanos1 interacts with and promotes p120 translocation 
to the cytoplasm, and suppress the Rho-inhibitory activity of p120 (Strumane et al., 
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2006). One intriguing hypothesis is that p120 is part of a Rho-regulatory complex, 
allowing for the rapid regulation of Rho activity at the cell membrane (e.g. the cadherin 
complex) or the cytoplasm.  
 
Interaction with Transcription Factors 
 The observed nuclear localization of p120 has led to speculation that p120 plays a 
role in gene regulation. This idea is supported by the interaction of p120 with two 
transcription factors; Kaiso (Daniel and Reynolds, 1999) and Glis2 (Hosking et al., 
2007). Kaiso was first identified in a Yeast-Two-Hybrid screen and was later identified as 
a transcriptional repressor that may link p120 to Wnt signaling (Kim et al., 2004). The 
nature of the Kaiso-p120 interaction remains unclear, but it has been proposed that p120 
can sequester Kaiso in the cytoplasm, relieving Kaiso’s transcriptional repression and 
thereby promoting gene transcription (Daniel, 2007). Glis2 is also a transcriptional 
repressor that is involved in neuronal differentiation. p120 promotes cleavage of Glis2, 
which can suppress transcriptional activity. p120 can therefore suppress the activity of 
two distinct transcriptional repressors, thereby promoting the transcription of their 
specific gene targets. 
 
Additional p120 Complexes 
 In addition to the binding partners already discussed, other p120 binding partners 
have been reported. In most cases, the precise functions of these interactions are poorly 
understood. p120 nuclear localization is promoted by an interaction with DF3/MUC1, a 
glycoprotein that is highly expressed in cancer cells (Li and Kufe, 2001). p120 may 
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regulate cell migration and adhesion via an interaction with another src-substrate, 
cortactin (Boguslavsky et al., 2007). p120 has been implicated in the processes of 
cytokinesis via its interactions with the cdk2/cyclin E complex (Chartier et al., 2007) as 
well as with microtubules (Franz and Ridley, 2004). At the cell membrane, p120 can 
interact with desmoglein 3 (Kanno et al., 2008) and the Gamma-Secretase complex (Kiss 
et al., 2008), facilitating crosstalk between cadherins and other adhesion receptors and/or 
membrane proteins. Thus, it appears there are a number of p120 functions mediated by 
protein-protein interactions that have yet to be understood.  
 
Hypothesis 
The Wnt signaling functions of -catenin were initially identified through protein 
interaction screens. By analogy, p120 binding partner studies have lagged behind, due in 
large part to the labile nature of p120 complexes. I hypothesize that novel p120-binding 
partners can be identified using in-cell crosslinking to stabilize otherwise-labile 
complexes followed by mass spectrometry analysis. Herein, I describe a novel approach 
(ReCLIP) to identify p120 binding partners, through which I have identified a novel 
physical and functional interaction between p120 and p160 Rho Kinase (ROCK1). 
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CHAPTER II 
 
MATERIALS AND METHODS 
 
Cell Lines and Cell Culture 
 
Cell lines and media 
Phoenix 293 cells were a kind gift from Dr. Linda Sealy. A431 and A431D 
epidermoid cervical carcinoma cell lines were obtained from Dr. Margaret Wheelock 
(University of Nebraska Medical Center). A431D cells expressing wild type (WT) or 
764AAA E-cadherin (Thoreson et al., 2000) were generated using the LZRS-MS-neo 
retroviral vector as described previously (Ireton et al., 2002), (Xia et al., 2006). A431, 
A431D, MCF-7, Caco-2, HCA-7 and MDCK II cells were cultured in DMEM 
(Gibco/Invitrogen) supplemented with 10% FBS (Hyclone) and 1% penicillin-
streptomycin (Gibco/Invitrogen). Phoenix 293 and 293T cells were cultured in DMEM 
supplemented with 10% Heat-Inactivated FBS and 1% penicillin-streptomycin.  
 
Drug treatments 
 Phorbol-12-Myrsitate-13-Acetate (PMA) (524400) and Y-27632 (688000) were 
purchased from EMD Biosciences. Prior to treatment, A431 or MCF-7 cells were washed 
twice with PBS and serum starved overnight with DMEM supplemented with 0.1% FBS. 
The next day, cells were treated with DMSO vehicle or 200 nM PMA for 30 minutes 
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unless otherwise indicated. For Y-27632 treatments, cells were treated with inhibitor or 
DMSO vehicle alone for 24 hours unless otherwise indicated.   
 
Calcium switch assay 
 A431 cells were plated onto glass coverslips (for immunofluorescence analysis) in 
standard DMEM growth media. Approximately 24 hours after plating, cells were serum 
starved overnight. The next day, starvation media was removed and replaced with Low 
Calcium Media (LCM) (Calcium-Free DMEM supplemented with 5.0 μM CaCl2). Cells 
were incubated in LCM for 2 hours, and 1.8 mM CaCl2 was added directly to cells for the 
indicated time intervals prior to processing. For control cells, 1.8 mM CaCl2 was added 
immediately to LCM to prevent calcium depletion. For cadherin-blocking experiments, 
cells were incubated with 5 μg/mL HECD1 (anti-E-cadherin mAb) and 2 μg/mL 6A9 
(anti-P-cadherin mAb) for 30 minutes prior to calcium restoration. 
  
Retroviral and Lentiviral Transduction 
 
Retrovirus and lentivirus production and infection 
 To generate retrovirus particles, the Phoenix 293 cells were transfected using the 
calcium phosphate method as described previously (Davis et al., 2003). Retrovirus 
constructs used were based on the LZRS-MS-neo and pRetro-Super (pRS) shRNA 
vectors described previously (Ireton et al., 2002, Davis et al., 2003). Virus was harvested 
48 hours post-transfection by passing the cell-culture media through a 0.45 μm filter. 
Target cells were transduced by incubation with retrovirus-containing media containing 4 
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μg/mL Polybrene. Approximately 48 hours post-infection, infected cells were selected 
using either G418 (for LZRS-neo transductions) or Puromycin (for pRS transductions).  
 To generate lentiviral particles, 293T cells were co-transfected with the pLKO.1 
shRNA plasmid of interest, pCMV-dR7.74psPAX2 packaging plasmid, and pMD2.G 
envelope plasmid using the calcium phosphate method as described previously (Brown et 
al., 2009). Lentivirus was harvested 48 hours post-transfection and target cells were 
transduced as described above. Approximately 48 hours post-infection, infected cells 
were selected using Puromycin.  
 
Plasmids 
 The LZRS-MS-neo (LZRS-neo) vector was used for exogenous expression of 
p120, E-cadherin, and ROCK1. p120 and E-cadherin constructs used are as follows: 
LZRS-neo mp120 1A, LZRS-neo mp120 3A, LZRS-neo mp120 4A, LZRS-neo mp120 
3A arm1 (Ireton et al., 2002), LZRS-neo mp120 3A arm1 CAAX (Xia et al., 2006), 
LZRS-neo mp120 1A 622-8 (Anastasiadis et al., 2000), LZRS-neo E-cadherin, and 
LZRS-neo 764AAA E-cadherin. p120 cDNAs were first cloned into the pMS shuttle 
vector prior to ligation into LZRS-neo. All point mutations were generated by site-
directed mutagenesis as described previously (Xia et al., 2003). 
 ROCK1 cDNA was obtained from Dr. Shuh Narumiya (Kyoto University) in the 
pCMX expression vector. To generate LZRS-neo ROCK1-GFP, the ROCK1 ORF was 
PCR amplified with the stop codon removed and subsequently ligated in pENTR 3C to 
generate pENTR-ROCK1 stop. pENTR-ROCK1 stop was recombined with LZRS-neo 
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GW-GFP using the Gateway Cloning system (Invitrogen) to generate LZRS-neo 
ROCK1-GFP.  
 For shRNA mediated knockdown of p120, pRS-hp120 was employed as 
described previously (Davis et al., 2003). For ROCK1 knockdown, Non-Target or 
ROCK1 shRNA constructs in the pLKO.1 lentivirus vector were purchased from Sigma. 
For all ROCK1-knockdown experiments described herein, cells transduced with ROCK1 
shRNA TRCN0000121094 are shown. Similar results were obtained using ROCK1 
shRNA TRCN0000002160. 
 
Antibodies 
The generation of monoclonal and polyclonal antibodies for p120 (pp120, 15D2, 
8D11, F1aSH) has been described (Wu et al., 1998). Of note, mAb 15D2 was used for all 
p120 immunoprecipitations unless otherwise noted, while mAb 8D11 is used as a control 
IgG because it does not recognize human p120. The generation of anti-phospho-S268, 
phosho-S288, phosho-T310, and phospho-T916, and phospho-S879 monoclonal 
antibodies has been previously described (Xia et al., 2004; Vaughan et al., 2007). Other 
antibodies used include anti-E-cadherin monoclonal antibody (BD Transduction), anti--
catenin rabbit polyclonal antibody (C-2081, Sigma), anti--catenin rabbit polyclonal 
antibody (C-2206 Sigma), anti-p42/44 MAPK (ERK1/2) rabbit polyclonal antibody (Cell 
Signaling), and anti-Focal Adhesion Kinase (FAK) rabbit polyclonal antibody (C-20, 
Santa Cruz), anti-ROCK1 rabbit polyclonal antibody (Chemicon), Ezrin monoclonal 
antibody (BD Transduction), anti-GFP monoclonal antibodies (Roche), and anti-tubulin 
monoclonal antibody (clone DM1A, Sigma). Anti-cd98 monoclonal antibody 4F2 was a 
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kind gift from Dr. Roy Zent (Haynes et al., 1981),
 
(Zent et al., 2000). Anti-E-cadherin 
and anti-P-cadherin monoclonal antibodies HECD1 and 6A9, respectively, were kind 
gifts from Dr. Margaret Wheelock. Secondary antibodies for western blot analysis 
include anti-mouse AlexaFluor 680 (Molecular Probes) and anti-rabbit IRdye 800 
(Rockland Immunochemicals). Secondary antibodies used for immunofluorescence 
analysis include anti-mouse IgG, anti-mouse IgG2a and anti-rabbit IgG or conjugated to 
AlexaFluor 488 or 594 (Molecular Probes). 
 
Crosslinking and Immunoprecipitation 
 
In-cell crosslinking 
 In-cell cross-linking was performed using Dithiobis[succinimidyl propionate] 
(DSP) and Dithio-bismaleimidoethane (DTME) (Pierce/Thermo Scientific). For each 
experiment, cross-linkers were freshly prepared as a 20 mM solution in Dimethyl 
Sulfoxide (DMSO) and diluted to the indicated final working concentrations in 
Phosphate-buffered saline, pH 7.4 (PBS, Fisher Scientific). Cells were washed twice with 
PBS at room temperature to remove all traces of media and incubated with the cross-
linker solution for 30 minutes at room temperature. After removal of the cross-linker 
solution, cells were incubated at room temperature for 10 minutes with quenching 
solution (20 mM Tris-Cl pH 7.4, 5 mM L-Cysteine). Quenching solution was then 
removed and cell lysates were prepared as described below. 
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Bead preparation 
  To prepare magnetic beads for immunoprecipitation, Protein G Dynabeads 
(Dynal/Invitrogen) were washed with Citrate Phosphate buffer pH 5.0 (25 mM citric acid, 
50 mM dibasic sodium phosphate) and incubated with either 15D2 or 8D11 monoclonal 
antibodies for 2 hours at room temperature with end-over-end rotation. Bead-antibody 
complexes were washed with citrate phosphate buffer, followed by two washes with 0.2 
M Triethanolamine (TEA) pH 8.2. Antibodies were covalently bound to Protein G beads 
by incubation 20 mM Dimethyl Pimelimidate (Sigma) in TEA for 30 minutes at room 
temperature with end-over-end rotation, followed by incubation for 15 minutes with 50 
mM Tris-Cl pH 7.5 to quench the crosslinking reaction. Subsequently, beads were 
washed three times with PBS-Tween. After washing with 0.1 M Glycine, pH 2.5 to 
remove non-covalently bound antibodies, beads where washed again with PBS-Tween 
and stored at 4
o
C.  
 
Lysate preparation, conventional immunoprecipitation, and western blot analysis 
 Lysis, immunoprecipitation, and western blot methods have been described 
previously (Xia et al., 2006). Briefly, cells were lysed in Radioimmunoprecipitation 
Assay (RIPA) buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% deoxycholic 
acid, 0.1% SDS) or Digitonin buffer (20 mM Tris pH 7.5, 150mM NaCl, 1% Digitonin) 
supplemented with protease and phosphatase inhibitors (1 mM PMSF, 5 mg/mL 
Leupeptin, 2 mg/mL Aprotinin, 1 mM EDTA, 50 mM NaF, and 1 mM NaVO4). Lysates 
were cleared by centrifugation and total protein concentrations were determined by BCA 
assay (Pierce/Thermo Scientific). For immunoprecipitation, the specified antibody was 
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added to the clarified lysate for 2 hours at 4
o
C with end-over-end rotation, followed by 
incubation with Protein G sepharose (GE Healthcare) for an additional hour at 4
o
C. Beads 
were washed with lysis buffer, resuspended in 2x Laemmli Sample Buffer (LSB), and 
boiled for 5 minutes. Lysates were prepared in LSB or non-reducing sample buffer (50 
mM Tris pH 6.8, 4% Glycerol, 1% SDS, 0.004% Bromophenol Blue) as indicated. Cross-
linked lysates were incubated with 50 mM DTT for 15 minutes prior to boiling to ensure 
cleavage of disulfide bonds within the cross-linkers. 
 Immunoprecipitations and whole cell lysates were separated by SDS-PAGE and 
transferred to nitrocellulose membranes (Whatman) for western blotting. Non-specific 
binding to membranes was blocked with 3% nonfat milk or 5% BSA (phospho-antibodies 
only) in TBS (10 mM Tris pH 7.4, 150 mM NaCl), and membranes were incubated with 
primary antibody in milk overnight at 4
o
C. Membranes were incubated with secondary 
antibody in Odyssey blocking buffer (Li-Cor) for 1 hour at room temperature. Antibodies 
were detected using the Odyssey infrared imaging system (Li-Cor). 
 
Reversible Cross-Link ImmunoPrecipitation (ReCLIP) procedure 
 Four 15 cm dishes of 90% confluent A431, MCF-7, MCF-10A, Caco-2, or HCA-
7 cells (approximately 1x10
8
 cells) were used for each experiment. RIPA lysis buffer was 
prepared fresh and filter-sterilized the day before cells were lysed. Cells were washed 
twice with freshly-prepared PBS pH 7.4 to remove all traces of media. Following 
removal of PBS, 10 mL of a 0.5 mM crosslinker solution in PBS (as described above) 
was added to the each plate. Cells were incubated with crosslinkers for 30 minutes at 
room temperature, with occasional agitation. Crosslinker solution was then removed, and 
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10 mL quenching solution was added to each plate for an additional 10 minutes. 
Following quenching, plates were placed on an ice-water bath and washed once more 
with chilled PBS, and lysed with freshly-prepared RIPA buffer plus protease and 
phosphatase inhibitors (1 mL RIPA buffer per dish). Lysates were homogenized using a 
23-gauge needle and cleared by centrifugation. Equal volumes of clarified lysate were 
incubated with either 15D2 (p120) or 8D11 (control) bound Protein G Dynabeads for 3 
hours at 4
o
C with end-over-end rotation. The beads were then washed 5 times with 1 mL 
RIPA buffer supplemented with protease and phosphatase inhibitors. p120 binding 
partners were eluted by incubating the beads with RIPA buffer supplemented with 50 
mM DTT in for 30 minutes at 37
o
C with end-over-end rotation. 
 For mass spectrometry analysis, eluates were boiled in freshly prepared LSB, 
separated by SDS-PAGE on Nu-PAGE 4-12% Bis-Tris gels (Novex/Invitrogen) and 
stained with “Blue Silver” colloidal coomassie stain (Candiano et al., 2004). The entire 
lane was excised and processed for shotgun analysis using single-dimension liquid-
chromatography tandem-mass spectrometry (LC-MS/MS) by the Vanderbilt University 
Medical Center Proteomics Laboratory (according to procedures described below). For 
silver stain analysis, 10% of the eluate was separated by SDS-PAGE and protein was 
visualized using Silver Stain Plus (Bio-Rad), according to the manufacturer’s protocols. 
Following staining, gels were imaged using the FluorChem-8900 Gel Documentation 
System (Alpha Innotech). 
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Mass spectrometry and protein identification 
Proteins were resolved by SDS-PAGE, visualized with colloidal coomassie stain, 
and protein bands of interest were excised and cut into 1 mm cubes and equilibrated in 50 
mM NH4HCO3.  Proteins were then reduced within the gel pieces with DTT (3 mM in 
100 mM NH4HCO3, 37°C for 15 min) followed by alkylation with iodoacetamide (6 mM 
in 50 mM NH4HCO3 for 15 min).  The gel pieces were then dehydrated with acetonitrile 
and rehydrated with 15 mL 12.5 mM NH4HCO3 containing 0.01 mg/mL trypsin (Trypsin 
Gold, Promega), and trypsin digestion was carried out for >2 h at 37°C.  Peptides were 
extracted with 60% acetonitrile, 0.1% formic acid, dried by vacuum centrifugation and 
reconstituted in 15 μL 0.1% formic acid. 5 μL of peptide hydrosylate were analyzed by 
C18 reverse-phase LC-MS/MS using a Thermo LTQ ion trap mass spectrometer 
equipped with a Thermo MicroAS autosampler and Thermo Surveyor HPLC pump, 
nanospray source, and Xcalibur 2.0 instrument control using standard triple-play 
methods.  Tandem MS data were analyzed with the Sequest algorithm to search a human 
subset of the UniRef100 database (Jan 23 2007, 223514 entries) using Xcorr cutoffs of 
1.8 for [M+2H]2+/2  ions and 2.5 for [M+3H]3+/3  ions .  In addition, the database 
contained a concatenated reverse decoy database to estimate false-discovery rates, which 
were at 5% or below 
 
Immunofluorescence Microscopy 
Cells were plated on glass coverslips 2 days before treatment and processing for 
immunofluorescence staining. Briefly, cells were fixed in 3% Paraformaldehyde for 30 
minutes, and permeabilized in PBS/0.2% Triton X-100 for 5 minutes. Cells were blocked 
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with PBS containing 5% BSA for 10 minutes. Cells were incubated with the indicated 
primary antibodies diluted in 5% BSA for 30 minutes, followed by secondary antibodies 
for another 30 minutes. To stain actin, AlexaFluor 488-conjugated Phalloidin was used in 
place of secondary antibody. Cells were stained with 0.5 μg/mL Hoechst dye for one 
minute to stain nuclei. Coverslips with stained cells were mounted onto glass slides using 
Prolong Gold anti-fade reagent (Invitrogen) and imaged using a Zeiss Axiovert 
fluorescence microscope with a 63x objective. Images were acquired and processed using 
Metamorph software (Molecular Devices). To quantify cell-cell contact localization of 
ROCK1, four distinct regions of the coverslip were imaged using a 20x objective. Total 
cells were quantified using Hoechst-dye nuclei staining, and cells with ROCK1 localized 
to junctions were manually counted using ImageJ. The percent of cells with ROCK1 
localized to cell-cell contacts in each field was calculated and averaged. Statistical 
analysis was performed using a 2-tailed t-test. 
 
In-vitro ROCK1 Kinase Assay 
 A431 cells were grown to 90% confluence and serum-starved overnight with 
DMEM supplemented with 0.1% FBS. The next day, cells were lysed in RIPA buffer and 
clarified lysates were incubated with anti-p120 mAb 15D2 for 1 hour, followed by 
incubation with Protein-G Sepharose beads for an additional hour. Beads were washed 
three times with RIPA buffer, followed by an additional 2 washes with ROCK1 Kinase 
Buffer (10 mM MOPS, 0.2 mM EDTA, 10 mM MgAc) without ATP. Following washing 
beads were incubated with 200 ng constitutively active ROCK1 (amino acids 17-535) 
(Millipore) in ROCK1 kinase buffer with 0.1 mM ATP for 15 minutes. Kinase reactions 
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were stopped by addition of 2x LSB and boiling samples for 5 minutes. p120 
phosphorylation was assessed by western blot using phospho-specific p120 monoclonal 
antibodies and anti-p120 pAb F1SH to detect total p120.  
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CHAPTER III 
 
RECLIP (REVERSIBLE CROSS-LINK IMMUNO-PRECIPITATION): AN 
EFFICIENT METHOD FOR INTERROGATION OF LABILE PROTEIN 
COMPLEXES 
 
Introduction 
Identifying functionally relevant protein-protein interactions remains a significant 
problem in discovery-based research. Affinity purification coupled with Mass 
Spectrometry (MS) analysis is a rapid, sensitive, and unbiased method for identifying 
novel protein-protein interactions. While ongoing technical advances have dramatically 
improved the sensitivity and efficiency of mass spectrometry instruments and methods, 
most experiments are limited by the quality of the sample itself. Current methods 
represent a compromise where recovery is sacrificed for specificity or vise versa. 
Conventional co-immunoprecipitation by itself is invariably accompanied by 
unacceptable background. A common solution is to add a second affinity purification 
step.  This Tandem-Affinity-Purification (TAP-tag) approach, however, minimizes 
background at the expense of transient and/or weak interactions that are lost because of 
the additional processing (Rigaut et al., 1999), (Puig et al., 2001).  
Here, I have used p120-catenin (hereafter p120) and the E-cadherin complex as a 
model to develop an approach that captures labile interactions without sacrificing 
specificity. Whereas - and -catenins bind cadherins with high affinity under a variety of 
conditions, the p120 interaction is relatively labile. In RIPA buffer, for example, p120 is 
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almost undetectable in cadherin immunoprecipitates, whereas the other catenins are 
efficiently recovered. Gentler detergents (i.e. NP-40) improve recovery, but are 
nonetheless relatively inefficient (Reynolds et al., 1994). Digitonin can effectively 
preserve p120 binding in some cell types, but appears to act selectively on soluble (as 
opposed to cytoskeleton tethered) complexes (Reynolds et al., 1994), (Kiss et al., 2008) 
and previous attempts using TAP methods have been unsuccessful due to extremely low 
recovery of p120 complexes (unpublished observations).  
Chemical crosslinkers have been employed to stabilize protein-protein 
interactions for structural studies (Studdert and Parkinson, 2007), or to demonstrate 
interaction between already suspected binding partners (Vretou et al., 2008). For 
example, it has been used successfully to capture transient dimerization of the Epidermal 
Growth Factor Receptor in response to ligand (Zhou et al., 1993). In particular, the cell-
permeable, lysine-reactive crosslinker Dithiobis[succinimidyl propionate] (DSP, also 
called Lamont’s Reagent) has been successfully used to facilitate co-immunoprecipitation 
of weakly interacting binding partners (Zhang et al., 2007). Recently, DSP-crosslinking 
has been combined with affinity-purification and mass spectrometry to identify novel 
binding partners (Salazar et al., 2009), (Humphries et al., 2009), suggesting that in-cell 
crosslinking can be used to characterize weak and transient complexes by mass 
spectrometry.  
 Here, using p120 and the cadherin complex as a model system, we describe an 
efficient approach that employs cell-permeable, thiol-cleavable crosslinkers to stabilize 
normally labile interactions (i.e. the p120 - E-cadherin interaction) in vivo prior to cell 
lysis and affinity purification. In our model, p120 was directly immunoprecipitated under 
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stringent conditions and binding partners were selectively eluted from the p120 “bait” by 
chemical cleavage of the crosslinker. Unlike other approaches, this elution scheme 
removes the target protein along with the beads and antibody from the final sample, 
resulting in very low background. Western blot and MS analyses revealed that all core 
components of the cadherin complex were efficiently recovered along with several novel 
candidates for direct or indirect p120 binding partners. This approach, which we have 
termed ReCLIP (Reversible Cross-Link Immuno-Precipitation) is simple and produced 
remarkably clean preparations of p120 binding partners for proteomic analyses.  These 
results suggest that ReCLIP provides high sensitivity without sacrificing specificity, and 
therefore provides a robust alternative to other affinity-purification methods. 
 
Results 
 
Determination of optimal crosslinker concentrations 
 We initially identified candidate crosslinkers and evaluated conditions for use. 
Two specific crosslinkers, Dithiobis[succinimidyl propionate] (DSP) and Dithio-
bismaleimidoethane (DTME), were chosen based on their distinct chemical properties. 
DSP reacts with primary amines and has a spacer-arm of 12 Å (Figure 8a), forming 
crosslinks between lysine residues of interacting proteins. DSP has been commonly used 
in a variety protein-interaction studies (Appenzeller et al., 1999), (Studdert and 
Parkinson, 2007) due in part to the high abundance of lysine residues in proteins. DTME 
reacts with sulfhydryl groups and has a spacer arm of 13.3 Å (Figure 8b), forming 
crosslinks between cysteine residues of interacting proteins. DTME would be expected to 
produce fewer crosslinks, however it may capture interactions that DSP cannot. While 
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Figure 8: Chemical structures of ReCLIP crosslinkers DSP and DTME. The 
chemical structures of DSP (a) and DTME (b) are shown, images were constructed with 
the DrawIt application in KnowItAll Informatics System v. 4.1 (Bio-Rad). DSP features 
NHS-ester reactive groups at both ends (a) while DTME features meleimide reactive 
groups (b). Note the central disulfide bond in each molecule, allowing for cleavage by 
reducing agents.  
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not commonly used, DTME has been successfully applied to protein-protein interactions 
studies (Casula et al., 2009). Importantly, both compounds are cell-permeable, allowing 
for in-cell crosslinking of endogenous complexes prior to cell-lysis. Additionally, both 
compounds are thiol-cleavable, allowing for “reversal” of the crosslinks via chemical 
cleavage by a reducing agent (i.e. DTT). 
Optimal crosslinker conditions were determined using A431 epidermoid 
carcinoma cells, a human epithelial cell line that has been used for a number of cell-cell 
adhesion studies (Norvell and Green, 1998), (Davis et al., 2003). A431 cells were washed 
with PBS and exposed for 30 minutes to increasing concentrations of DSP or DTME in 
PBS, pH 7.4.  Cells were then lysed at 4˚C in RIPA and the lysates treated for 15 min 
with DTT (reducing, panels b and d) or not (nonreducing, panels a and c), as indicated.  
Samples were then analyzed by SDS-PAGE, followed by Western blotting for E-cadherin 
(top panels) or p120 (bottom panels). 
Figure 9a shows a dose-dependent reduction in monomeric E-cadherin (top panel, 
arrowhead) and the simultaneous appearance of crosslinked complexes across the top of 
the gel that are too large to resolve (arrow). Note that the monomeric E-cadherin (and 
p120, lower panel) is decreased at 0.5 mM DSP and almost absent at 1.0 mM, indicating 
that the vast majority of E-cadherin and p120 is crosslinked into high molecular 
complexes at these concentrations. Figure 9b shows that monomeric protein is efficiently 
recovered by addition of DTT.  Note that at 0.5 mM DSP, virtually all of the monomeric 
E-cadherin and over half of the monomeric p120 are recovered (compare lanes 6 in a and 
b, upper and lower panels respectively), and that the high molecular weight bands are no 
longer present. It is not entirely clear why the recovery of p120 in whole cell lysates is  
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Figure 9: Titration of intracellular cross-linking of p120 and E-cadherin. Western 
blot analysis of E-cadherin (top panels) and p120 (bottom panels) in whole cell lysates of 
A431 cells treated with the indicated concentrations of DSP (a, b) or DTME (c, d) 
between 0.01 mM and 1.0 mM. Samples were prepared under non-reducing (a, c) and 
reducing conditions (b, d) as indicated. Arrowheads indicate monomeric E-cadherin and 
p120, large cross-linked species are indicated with arrows, smaller crosslinked E-
cadherin species are indicated with a diamond (u), and a possible cysteine-induced E-
cadherin dimer is indicated with an asterisk (*). 
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less efficient than that for E-cadherin.  The difference, however, is not generally observed 
in immunoprecipitates, suggesting that the phenomenon may reflect competition for 
reducing agent among the large number of crosslinked proteins present in the whole cell 
lysate. 
Crosslinking with DTME was less efficient, as evidenced by the relatively high 
levels of monomeric E-cadherin remaining at the 1.0 mM dose (panel c, compare lanes 1 
and 6).  This is consistent with the lower abundance of cysteine residues relative to 
lysine. Nonetheless, the appearance of progressively larger E-cadherin-containing 
complexes with increasing DTME indicates the presence of crosslinked species. The 
faster migrating band (Figure 9c, diamond) probably represents a partial complex.  The 
exact content is not known, but p120 is clearly absent.  Further crosslinking generates 
p120-containing higher order complexes, which are too large to resolve by SDS-PAGE 
(arrow). In these non-reduced samples, an additional E-cadherin band is present even in 
the absence of cross-linker (asterisk). The precise identity of this E-cadherin complex is 
unclear, but it may represent cadherin dimers caused by the addition of cysteine to 
quench the DTME crosslinking reaction, as dimerization is induced, in part, by cysteine 
mediated disulfide bonds within the extracellular domain (Boggon et al., 2002), 
(Troyanovsky et al., 2003). Interestingly, for reasons not entirely clear, DTME appears to 
crosslink p120 more efficiently than E-cadherin, as evidenced by significant loss of 
monomeric p120 (panel c, compare lanes 1 through 6).  
Based on these data, we chose 0.5 mM DSP and 0.5 mM DTME as optimal 
concentrations for subsequent experiments.  In the case of DSP, 1.0 mM was more 
effective than 0.5 mM, but I chose the lesser of the two to limit nonspecific capture. For 
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DTME, there was no apparent difference between 1.0 and 0.5 mM so the lesser amount 
was used. 
 
Efficacy, efficiency, and specificity of crosslinking with DSP and DTME 
 Next, I used the E-cadherin – p120 interaction as a model to assess the efficacy of 
DSP and DTME under the above conditions.  The amount of E-cadherin co-
immunoprecipitating with p120 was determined after in-cell crosslinking with DSP or 
DTME (Figure 10a).  Cell lysis in a digitonin-containing buffer (without crosslinking) 
was used as a reference (Figure 10a, lane 1), because it is relatively effective in A431 
cells at preserving the p120 – E-cadherin interaction (Kiss et al., 2008). In contrast, the 
remaining samples were treated with DSP, DTME, or vehicle alone (DMSO), as above, 
and lysed in RIPA buffer.  p120 was then immunoprecipitated from all samples, eluted in 
reducing LSB, and analyzed by SDS-PAGE and Western blotting.  
 Figure 10a shows that E-cadherin recovery from p120 immunoprecipitates after 
DSP crosslinking was as good, if not better, than that obtained from the digitonin lysate 
(compare lanes 1 and 3).  DTME was less efficient (lane 4), whereas no E-cadherin was 
recovered in the absence of crosslinker (i.e. DMSO, lane 2). Thus, E-cadherin was not 
recovered in RIPA alone, but crosslinking with DSP preserved the interaction.  
Moreover, irrelevant cytoplasmic (i.e. ERK1/2) and membrane-associated (i.e. Focal 
Adhesion Kinase) proteins were absent from the p120 immunoprecipitates but clearly 
present in whole cell lysates. Thus, DSP and DTME crosslinking appears to be quite  
specific under these conditions.  
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Figure 10: In-cell cross-linking preserves the interaction of p120 and E-cadherin 
and is specific for interacting proteins. (a) Western blot analysis of p120, E-cadherin, 
FAK, and p42/44 MAPK in p120 immunoprecipitates and lysates from A431 cells lysed 
in 1% digitonin or RIPA buffer following treatment with DMSO vehicle or 0.5 mM 
cross-linker as indicated. (b) Cadherin-negative A431-D cells, and A431-D cells stably 
expressing wild type (WT E-cad) or p120-uncoupled (764 E-cad) E-cadherin were 
prepared and analyzed as in A. (c) Western blot analysis of p120, E-cadherin, -catenin, 
and -catenin in p120, control IgG immunoprecipitates, and lysates from A431 cells 
treated as in panel a. 
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To further assess specificity, I asked whether E-cadherin and p120 could be crosslinked 
under conditions where physical interaction is selectively uncoupled (Figure 2b).   Our 
lab has previously described a minimal E-cadherin mutant (E-cad 764AAA) that is 
physically uncoupled from p120 but nonetheless forms cell-cell junctions and interacts 
normally with -catenin (Thoreson et al., 2000).  In Figure 10b, I introduced WT E-
cadherins (lanes 5-8) or 764AAA E-cadherin (lanes 9-12) into the A431D cell line, a 
cadherin-negative A431 variant. The absence of E-cad 764AAA in p120 
immunoprecipitations (lanes 9-12, top panel) shows clearly that this mutant is not 
crosslinked to p120, implying that direct physical interaction is indeed essential.  In 
contrast, WT E-cadherin is efficiently crosslinked (lanes 5-8, top panel). 
 To further test the efficacy of crosslinking, I extended the analysis to - and -
catenins, which form a tertiary (indirect) complex with p120 via E-cadherin (Figure 10c).  
Interestingly, the entire complex is efficiently crosslinked by DSP (lane 4).  -catenin, in 
particular, was easily recovered relative to the DTME or digitonin methods. The middle 
panels (lanes 5-8) show that negative-control immunoprecipitation with a p120 
monoclonal antibody that does not recognize human p120 (control IgG, mAb 8D11) 
under conditions identical to the first panel (lanes 1-4) does not bring down members of 
the cadherin complex.  
 
Reversible Cross-Linking Immuno-Precipitation (ReCLIP) for Mass Spectrometry 
 Figure 11 illustrates the procedure I have developed for rapid and clean isolation 
of binding partners for MS analysis. The schematic (panel a) shows immunoprecipitation 
of a crosslinked p120 complex followed by selective elution of the 
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Figure 11: Elution of binding partners from p120. (a) A schematic of the elution 
strategy. Following immunoprecipitation and washing of cross-linked complexes on p120 
mAb beads, binding partners are released by incubation with DTT in RIPA buffer, 
cleaving the cross-links and releasing interacting proteins from p120. (b) A representative 
western blot demonstrating depletion of p120 from A431 cell lysates following 
immunoprecipitation with p120 mAb beads of control IgG beads. Tubulin is shown as a 
loading control. (c) Elution of known binding partners, but not p120, from p120 mAb 
beads. Whole cell lysate is shown as a control, and 10% of the DTT eluate was analyzed 
for E-cadherin, -catenin, -catenin, and p120 by Western blot. 
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individual components. Binding partners are efficiently recovered by breaking the 
crosslinks with reducing agent, essentially reversing the procedure. With the antibody 
covalently bound to the bead (see Bead preparation in chapter two), DTT releases 
crosslinked binding partners only. The most abundant protein  ‘contaminants’, mAb 
15D2 and mAb-bound p120 itself (the bait) are discarded along with the beads, resulting 
in a highly purified mixture of eluted binding partners.  Panel b illustrates the efficiency 
of the immunoprecipitation, as evidenced by depletion of p120 from the supernatant 
(panel b, compare lanes 1 and 2).  Panel c shows that the coimmunoprecipitated E-
cadherin is efficiently recovered by DTT elution (panel c, top panel, compare lanes 1 and 
2) while p120 is essentially absent, having been discarded with the beads (panel c, bottom 
panel, lane 2). Furthermore, immunoprecipitation using control IgG (mAb 8D11) does 
not deplete p120 from the lysate (panel b, lane 3) and E-cadherin and associated catenins 
are not detected in the DTT eluate (panel c, lane 3). 
 
Efficacy of ReCLIP 
 To test the efficacy of ReCLIP, p120 and control elutions from A431 cells 
crosslinked with DSP were subjected to shotgun analysis by single-dimension liquid 
chromatography tandem mass spectrometry (LC-MS/MS). Relative protein abundance 
was measured using the total number of peptides detected for each protein (spectral 
counts). Core p120 binding partners were easily identified, as evidenced by high spectral 
counts for E-cadherin and the catenins (Table 2).  Note, however, that spectral counts are 
only partly indicative of protein abundance. For example, E-cadherin is consistently 
under-represented relative to its size, which is similar to the catenins. Importantly, 
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cadherin proteins are not detected control pull downs (i.e. zero peptides), as shown in 
Table 2. Nonspecific background (i.e., proteins detected in both experimental and control 
samples) was remarkably low, consisting primarily of common artifacts such as 
chaperones, metabolic proteins, and highly abundant cytoskeletal proteins, as illustrated 
in Table 3.  
Table 2: Recovery and identification of core p120 binding partners using ReCLIP. 
Average spectral totals for E-cadherin, -catenin, -catenin, and Plakoglobin from 3 
independent ReCLIP experiments from A431 cells treated with DSP. No peptides for 
these proteins were identified in the corresponding control samples. 
 
Protein UniProt 
Accession 
Average spectral 
count in p120 IP 
Standard 
Error 
Average spectral 
count in control IP 
E-cadherin IPI00000513.1 9 2.11 0 
-catenin IPI00215948.4 38 9.17 0 
-catenin IPI00017292.1 24 6.07 0 
Plakoglobin IPI00554711.2 12 5.08 0 
 
 
Effects of simultaneous DSP and DTME crosslinking  
 Next, I asked whether use of DSP and DTME together is more efficient than 
either one alone. Figure 12a shows the number of distinct peptides (per protein) of 
cadherin complex proteins detected using individual or combined crosslinkers. For E-
cadherin and -catenin, combining DSP and DTME was clearly more efficient than 
individual usage, whereas no little or no improvement was observed for -catenin and 
Plakoglobin. The same result is illustrated by Western blotting (Figure 12b) using E-
cadherin as the readout. In the experiment shown, the DSP + DTME combination was 
highly effective (compare lanes 7 and 8), whereas each compound by itself was less 
efficient (compare lane 1 and 2, and lane 4 and 5).  
 The efficacy of ReCLIP under three crosslinking conditions was further evaluated 
by SDS-PAGE and silver staining (figure 12c). The data indicate an excellent signal to  
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Table 3: Common background proteins detected by ReCLIP in A431 cells. Proteins 
detected in both p120 and control eluates are listed. The highest single spectral count 
detected for each in p120 and control eluates across all experiments in figures 11 and 12 
are shown. 
 
Protein 
UniProt 
Accession p120 Control 
Alpha-actinin-4 IPI00013808.1 8 78 
D-3-phosphoglycerate dehydrogenase IPI00219018.7 3 6 
Elongation Factor 1 alpha 2 IPI00014424.1 6 4 
Elongation Factor 2 IPI00186290.6 6 3 
TUBA1C  IPI00166768.2 4 6 
heat shock protein 90kDa alpha (cytosolic), class A 
member IPI00382470.3 6 5 
14-3-3 protein epsilon IPI00000816.1 9 3 
61 kDa protein IPI00472102.3 3 5 
Fatty acid synthase IPI00026781.2 11 9 
Isoform 1 of L-lactate dehydrogenase A chain IPI00217966.7 2 3 
Isoform 1 of Protein-L-isoaspartate(D-aspartate) O-
methyltransferase IPI00411680.8 7 2 
Protein disulfide-isomerase A3 IPI00025252.1 3 6 
Isoform M1 of Pyruvate kinase isozymes M1/M2 IPI00220644.8 8 9 
Isoform alpha-enolase of Alpha-enolase IPI00465248.5 4 2 
Peroxiredoxin-1 IPI00000874.1 6 8 
Phosphoglycerate kinase 1 IPI00169383.3 3 5 
Src substrate cortactin IPI00029601.4 2 15 
Heat shock 70 kDa protein 1L IPI00301277.1 3 3 
Isoform 1 of LIM and SH3 domain protein 1 IPI00000861.1 2 5 
Isoform Short of RNA-binding protein FUS IPI00221354.1 2 6 
Transketolase IPI00643920.2 6 8 
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Figure 12: Cross-linkers can be combined to enhance complex recovery. (a) Average 
number of distinct peptides identified in 2 LC-MS/MS runs for E-cadherin, -catenin, -
catenin, and plakoglobin from A431 cells treated with DSP, DTME, or both compounds 
simultaneously (DSP + DTME). Error bars represent standard error of the mean. 
Background levels were similar across all conditions. (b) Western blot analysis of E-
cadherin levels in lysates (Lysate), p120 eluates (p120), and control IgG eluates (Control) 
from A431 cells treated with the indicated cross-linkers. (c) Silver stain analysis of total 
protein recovery from p120 and control IgG eluates from each condition (DSP, DTME, 
or DSP + DTME). (d-f) Average distinct peptide recovery of 15 additional putative p120 
binding partners under each cross-linking condition. Proteins were grouped based on 
whether more peptides were detected using the combination of DSP and DTME (d), DSP 
alone (e) or DTME alone (f). 
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noise ratio across all three conditions, with very few bands detectable in control IgG 
lanes (lanes 2, 4, and 6).  For each condition, some of the bands were unique, as 
expected.  Notably, combining DSP and DTME captured most of the individual bands 
observed with either crosslinker alone (compare lane 5 with lanes 1 and 3) while 
background remained remarkably low (compare lanes 5 and 6). These data indicate that 
regardless of the crosslinker used, ReCLIP provides robust recovery with very low 
background. 
 In addition to the core components of the cadherin complex, I identified at least 
15 unique candidate p120 binding partners in MS analysis, and grouped them according 
to the condition that resulted in the highest number of peptide hits (Figure 12 d-f). For 
example, figure 12d contains the candidates for which DSP and DTME together yielded 
more hits than DSP (e) or DTME (f) alone. The cutoff for inclusion was a minimum of 
two hits against a background of zero, although the majority exceeded these criteria. As 
expected, the highest number of peptide hits for most of the candidates was obtained 
when DSP and DTME were combined (panel d). However, for five of the candidates, the 
highest number of hits was obtained using DSP alone (e), whereas DTME was optimal 
for only one protein (f). Interestingly, five of the candidates were captured only when 
DSP and DTME were used together. On the other hand, combining DSP and DTME 
prevented capture of three candidates (MSH2, GOLGA4, and AIFM1). In general, the 
use of both DSP and DTME together was most effective in that the majority of 
candidates (12/15) were detected and only three were missed.  With DSP or DTME 
alone, just over half of the candidates (8/15) were missed. Overall, these data suggest that 
the most effective approach is to combine DSP and DTME, but this approach may not be  
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ideal for all proteins. Thus, it is recommended that investigators test each crosslinker 
individually and in combination in order to determine the appropriate ReCLIP condition 
for a given target protein. 
 
p120 interacts with cd98 indirectly through E-cadherin 
 Mass spectrometry analysis identified cd98 in p120 eluates, consistent with an 
earlier report that cd98 could be recruited to cell-cell junctions by E-cadherin (Nakamura 
et al. 1999). To study the relationship between p120, cd98, and E-cadherin, cd98 
localization was analyzed by immunofluorescence in A431 and cadherin-negative A431-
D cells expressing wild type or p120-uncoupled E-cadherin. In A431 cells, cd98 localizes 
prominently at cell-cell junctions along with p120 (figure 13a). In the absence of E-
cadherin, cd98 is diffusely localized throughout the cell, with no detectable co-
localization with p120 (figure 13b, top row). In the presence of wild-type E-cadherin, 
both cd98 and p120 are efficiently recruited to cell-cell junctions (b, middle row, arrows). 
Expression of the p120-uncoupled 764AAA E-cadherin also recruits cd98 to cell-cell 
junctions (c, lower row, arrows), while p120 remains diffusely localized in the cytoplasm. 
This result indicates that p120 is not necessary to recruit cd98 to the cadherin complex. 
These data suggests that cd98 binds to E-cadherin (or another component of the 
complex), but not p120. 
 
Discussion 
Here, I have used reversible in-cell crosslinking to develop an extremely efficient 
method (ReCLIP) for studying protein complexes by mass spectrometry. The component  
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Figure 13: Indirect association of p120 and cd98. (a) Immunofluorescence analysis of 
endogenous p120 (green) and cd98 (red) in paraformaldehyde fixed A431 cells. Co-
localization and nuclei (blue) is shown in the merged images. (b) Immunofluorescence 
analysis of endogenous p120 (green) and cd98 (red) in paraformaldehyde fixed parental 
A431D cells and A431D cells expressing wild type (Wild Type E-cadherin) or p120-
uncoupled (764 AAA E-cadherin) E-cadherin. Arrows indicate junction-localized cd98. 
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techniques by themselves are not necessarily novel, but they are uniquely combined and 
optimized to generate a powerful method for studying labile complexes. The single 
immunoprecipitation approach minimizes sample loss, a common problem in TAP 
methods. Furthermore, covalent crosslinking preserves relevant interactions despite 
stringent lysis and washing conditions that reduce background. Thus ReCLIP appears to 
be particularly powerful for studying labile protein interactions that in principle could be 
lost using TAP approaches. 
Among the several optimized parameters of the ReCLIP method, two in particular 
turn out to be critical.  First, in-cell crosslinking covalently stabilizes endogenous 
interactions (as they occur in vivo). Thus, weak or transient interactions are captured in 
situ and retained, regardless of subsequent lysis and washing conditions, until the very 
end of the procedure when the product is eluted. Second, the elution method itself is both 
gentle and highly selective. A major difference between ReCLIP and other methods is 
that only putative binding partners are eluted when the crosslinks are cleaved (see Figure 
11a). Thus, beads, antibody, and other components of the solid phase, including the bait 
itself (in this case, p120) are completely absent from final sample. The removal of bait 
and immunoprecipitating antibodies from the sample is important because these are by 
far the most abundant protein contaminants present in most methods.  
A potential consideration when using ReCLIP in conjunction with MS is that 
some of the recovered peptides are covalently bound by a cleaved crosslinker. After 
cleavage by reducing agent, half of each crosslinker remains attached to a target residue 
in the crosslinked protein. In addition, bound crosslinker may alter proteolytic cleavage 
patterns, as has been demonstrated for other lysine modifications (Cameron et al., 1985). 
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In addition The cleaved crosslinker alters peptide mass and can prevent recognition by 
standard MS algorithms (Baldwin, 2004). Both events (mass-shift and reduced cleavage) 
can reduce the number of peptides generated and/or detected. Such complications are not 
likely to affect the data significantly because crosslinked peptides represent only a small 
fraction of the total number generated following digestion of the sample with trypsin. The 
effect is further limited by using the minimal effective concentration of the crosslinker, as 
determined by preliminary titration experiments. It is also possible to identify modified 
peptides by re-analyzing the spectra using a subset database that allows for the extra mass 
(105.16 Da per Lysine for DSP and 159.21 Da per Cysteine for DTME) produced by the 
cleaved crosslinker (Nesvizhskii et al., 2006). 
One potential drawback to ReCLIP is that very low molecular weight proteins 
might be missed because there are fewer available sites for crosslinking, and fewer tryptic 
peptides to detect.  For example, if a protein is crosslinked and contains only two tryptic 
peptides, one will be missed due to the crosslink modification.  Such proteins would be 
overlooked because the score (one peptide against zero background) is below the cutoff 
for positive identification. Thus, small proteins (e.g. small GTPases such as RhoA) may 
be overlooked, because few unmodified peptides are available. Thus, it is important to 
consider protein size and peptide coverage when assessing proteins with relatively low 
peptide scores (e.g. two peptides against zero background). 
ReCLIP has been optimized to study endogenous complexes using a monoclonal 
antibody. By design, this allows physiologically relevant complexes to be recovered with 
a relatively high degree of specificity. However, ReCLIP can still be used in conjunction 
with epitope-tags (e.g., Flag, Myc, HA epitope tags) in cases where specific antibodies 
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are not available.  Protein over-expression, however, may increase nonspecific 
interactions.  For example, we have noticed that components of the proteosome are 
selectively identified under such conditions. Presumably, the cell is targeting the excess 
protein for degradation and we are then crosslinking it to components of the proteosome. 
It is possible that we missed certain previously identified p120 binding partners (e.g. 
Kinesin Heavy Chain (Chen et al., 2003), (Yanagisawa et al., 2004)) for this reason, as 
the interaction between p120 and Kinesin Heavy Chain is more efficiently detected under 
conditions of p120 over-expression. Alternatively, the interaction may be different or 
absent in A431 cells.  
Surprisingly, Kaiso was not identified as a p120 binding partner by ReCLIP.  
However, Kaiso is a relatively low abundance transcriptional repressor found primarily in 
the nucleus in cultured cells (Daniel and Reynolds, 1999).  Thus, it is possible that spatial 
separation, low Kaiso expression, low interaction stoichiometry, or any combination 
thereof ultimately limits the sensitivity of ReCLIP.  Of note, p120 and Kaiso can be 
detected by conventional co-immunoprecipitation in gentle detergent buffers (Daniel and 
Reynolds, 1999), suggesting that low abundance of Kaiso is not by itself the limiting 
factor.  Instead, cell lysis without prior crosslinking may actually facilitate such 
interactions by permitting the mixing of proteins from otherwise spatially separate pools 
(e.g. nuclear Kaiso and cytoplasmic p120). With ReCLIP, protein complexes are 
crosslinked in situ and then lysed in RIPA, a stringent buffer designed expressly to be 
compatible with antibody-antigen interactions while preventing nonspecific and/or weak 
interactions. Thus, some events that occur post-lysis (e.g. the p120-Kaiso interaction) will 
undoubtedly be prevented by the ReCLIP lysis and washing conditions.  On the other 
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hand, this feature of ReCLIP may allow one to selectively capture physiological 
complexes under a defined condition and time interval, potentially identifying 
interactions that occur transiently in response to a stimulus. 
In addition to the cadherin complex, I identified several candidate p120 binding 
partners (Figure 4 c-e) including p160 Rho Kinase (ROCK1). ROCK1 is a prominent 
effector of RhoA that regulates the acto-myosin machinery and other signaling pathways 
(Riento and Ridley, 2003). This novel interaction, which will be described in chapter 
five, is consistent with other known roles of p120.  For example, p120 regulates the 
activity of RhoA (Anastasiadis et al., 2000) and can associate with p190 RhoGAP at the 
adherens junction (Wildenberg et al., 2006).  ROCK1 has not been linked to p120 by 
other methods (e.g. conventional immunoprecipitation and TAP-Tag), consistent with the 
apparent increased sensitivity of ReCLIP. Interestingly, no Rho-family GTPases were 
detected using ReCLIP, including RhoA, which has been reported to directly interact 
with p120 (Magie et al., 2002), (Castaño et al., 2007). A potential explanation for this 
result is the inherent bias of mass-spectrometry against small proteins. Nonetheless, the 
recovery of ROCK1 along with its substrate Villin-2/Ezrin suggests that a functional Rho 
complex associates with p120.  
Another candidate binding partner, cd98 (also known as 4F2 Heavy Chain), 
appears to reflect capture of a tertiary interaction.  In general, tertiary (as apposed to 
direct) interactions are considerably more difficult to capture by conventional methods, 
but in principle could be significantly stabilized by limited crosslinking. cd98 is an 
integral membrane protein that forms a heterodimer with the LAT-2 amino-acid 
transporter (also known as 4F2 Light Chain) (Nakamura et al., 1999). cd98 also regulates 
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1-integrin clustering (Henderson et al., 2004), (Cai, 2005), (Kim and Hahn, 2008) and 
heterotypic cell-cell interactions (Nguyen et al., 2008). Interestingly, a previous study 
suggested the recruitment of cd98 to cadherin-based cell-cell junctions (Nakamura et al., 
1999). Consistent with this report, I find that cd98 co-localizes precisely with E-cadherin 
and p120 in A431 cells (see Figure 13a).  However, in E-cadherin reconstitution 
experiments in A431D cells, cd98 is also recruited to both wild type and p120 uncoupled 
E-cadherin complexes, indicating that the direct interaction is not with p120 itself, but 
instead to some other member of the E-cadherin complex (see Figure 13b). As with 
ROCK1, I have not detected cd98 by other methods.  Importantly, the indirect association 
of p120 with cd98 provides additional evidence that ReCLIP can routinely capture 
tertiary interactions that would otherwise be lost, making it attractive for interactome 
mapping studies.    
In summary, I have developed ReCLIP (Reversible Cross-Link Immuno-
Precipitation), an approach designed expressly to retain weak interactions without 
sacrificing specificity and/or sensitivity. The procedure is relatively simple and yet 
generates excellent signal-to-noise ratios in MS analyses. Although I have focused on the 
cadherin complex as a model system, the method should be broadly applicable, provided 
users optimize crosslinkers and immunoprecipitation conditions for their own targets. 
Overall, ReCLIP offers a potentially powerful alternative to previously described 
affinity-purification approaches and appears to be particularly suitable for interrogating 
labile protein complexes. 
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CHAPTER IV 
 
ROCK1 PHYSICALLY ASSOCIATES WITH THE CADHERIN COMPLEX IN A 
P120-DEPENDENT MANNER 
 
Introduction 
 Establishment and maintenance of cell-cell adhesion requires the coordination of 
a wide array of signaling events. Modulation of the actin cytoskeleton is particularly 
important to maintain strong cell-cell adhesion. As discussed in Chapter one, the cadherin 
complex is functionally linked to the actin-cytoskeleton via -catenin, and disruption of 
the actin cytoskeleton dramatically reduces cell-cell adhesion (Fischer and Quinlan, 
1998). Coordination of the actin-cytoskeleton and cell-cell adhesion is important for the 
integrity of epithelial sheets with a network of apical stress fibers connected across 
multiple adjacent cells via adherens junctions (Vaezi et al., 2002). The precise physical 
interactions between cadherins and the acto-myosin network remain unclear. Although -
catenin physically interacts with both actin and the cadherin complex, recent work has 
suggested that -catenin cannot interact with both actin and cadherins simultaneously 
(Yamada et al., 2005).  
While the physical links between the acto-myosin network and the cadherin 
complex remain poorly understood, the functional links between them are more apparent. 
One of the major signaling pathways involved is the RhoA pathway. Early studies using 
dominant-active and dominant-negative RhoA mutants demonstrated that both excess 
activation and inhibition of Rho signaling can ablate cell-cell adhesion, presumably by 
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disrupting normal cytoskeletal organization (Braga et al., 1997), and junction maturation 
and cell-type can influence the precise effects of these GTPases (Braga et al., 1999). 
Furthermore, cadherins themselves can regulate the activity of Rho GTPases (Betson et 
al., 2002; Fukuyama et al., 2006). 
 Rho kinase, a major effector of RhoA, can regulate cadherin function in both a 
positive and negative manner. For example, ROCK promotes vascular permeability by 
disrupting VE-cadherin based junctions (Wójciak-Stothard et al., 2001). In epithelial 
cells, ROCK activity disrupts adherens junctions downstream of RhoA, while another 
RhoA effector, mDia, promotes adherens junction assembly (Sahai and Marshall, 2002). 
Furthermore, ROCK activity is required for the loss of E-cadherin during TFG- induced 
Epithelial-to-Mesenchymal Transition (Bhowmick et al., 2001). In contrast, inhibition of 
ROCK leads to a failure of epithelial polarization and blocks the formation of new tight 
junctions and adherens junctions in a calcium switch assay (Walsh et al., 2001). Recently, 
studies in human embryonic stem cells have demonstrated that ROCK activity is required 
for tight cell-cell adhesion (Harb et al., 2008). Similarly, suppression of RhoA and 
ROCK can reduce cellular aggregation and N-cadherin expression in differentiating 
neurons (Laplante et al., 2004). Furthermore, recent work has demonstrated that Myosin 
II, a direct target of ROCK, is essential for cell-cell adhesion and cadherin clustering (Li 
et al., 2010; Shewan et al., 2005; Smutny et al., 2011). 
 As discussed above, several lines of evidence point to a functional relationship 
between cadherins in ROCK signaling. Given its role in regulating both Rho GTPases 
and the cadherin complex, p120 is an attractive candidate to mediate this functional 
interaction. In chapter three, I identified p160 Rho Kinase (ROCK1) as a candidate p120 
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binding partner using ReCLIP. This result suggests that ROCK1 may physically associate 
with p120 and the cadherin complex in order to regulate cell-cell adhesion.  
 
Results 
 
Identification of p160 Rho Kinase as a p120 binding partner 
 In p120 ReCLIP samples from A431 cells, 15 distinct peptides of ROCK1 were 
recovered, covering 12.8% of the total amino-acid sequence. No ROCK1 peptides were 
detected in the control pulldowns with an irrelevant IgG. Sequence alignment analysis 
revealed that all but two peptides (mapped to the highly conserved kinase domain) were 
specific to ROCK1 rather than ROCK2 (Table 4). As Figure 14a illustrates, Peptides 
from multiple distinct regions of ROCK1 were detected, with the majority (11/15) 
representing the predicted coiled-coil domain. Additionally, ROCK1 was detected in 
immunoprecipitations from Caco-2 colorectal adenocarcinoma, MCF-7 mammary 
adenocarcinoma, and MCF-10A mammary epithelial cells (Table 5, Appendix A), 
suggesting this interaction is relevant in other epithelial cell types. 
 
ROCK1 physically associates with p120 at cell-cell junctions 
The identification of ROCK1 as a p120 binding partner was confirmed in A431 
cells by crosslink immunoprecipitation experiments. As figure 14b illustrates, ROCK1 
can be co-immunoprecipitated with p120 from DSP-crosslinked A431 cells using 2 
separate p120 antibodies (pp120 and 15D2, lanes 2 and 3), but not with an antibody that 
does not recognize human p120 (IgG, lane 4)). This interaction appears to have relatively 
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Figure 14: Identification of p160 Rho Kinase (ROCK1) as a p120 binding partner. 
(a) A schematic of ROCK1, with the distribution of unique peptides for each region of 
the protein. (b) Western blot analysis of ROCK1 and p120 in a whole cell lysate, p120, 
and control immunoprecipitates from DSP-crosslinked A431 cells. ROCK1 is pulled 
down with 2 separate p120 monoclonal antibodies (15D2 and pp120) but not a control 
IgG. 
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Table 4: ROCK1 peptides detected in p120 ReCLIP samples. The identified sequence 
and specific location ROCK1 peptides identified by mass spectrometry in p120 ReCLIP 
samples. Identified sequences were compared to the full sequence of ROCK1 and 
ROCK2. 
 
Peptide Location 
ROCK 
Domain ROCK1 ROCK2 
Detection in 
control 
AESEQLAR  899 - 906 Coiled-coil + - - 
GAFGEVQLVR  85 -  94 Kinase + + - 
IEGWLSVPNR  1121 -30 PH + - - 
LLEFELAQLTK  820 - 830 Coiled-coil + - - 
NIDNFLSR  51 -  58 N-terminus + - - 
SLQESLQK  423 - 430 Coiled-coil + - - 
YLSSANPNDNR  405 – 415 Coiled-coil + - - 
INEYQR  495 - 500 Coiled-coil + - - 
ITSLQEEVK  631 - 639 Coiled-coil + - - 
LLLQNELK  784 - 791 Coiled-coil + - - 
GLLEEQYFELTQESK  907 - 921 Coiled-coil + - - 
NLESTVSQIEKEK  476 - 488 Coiled-coil + - - 
NVENEVSTLKDQLEDLKK  511 - 528 Coiled-coil + - - 
SDSAFFWEER  116 – 125 Kinase + + - 
YLSSANPNDNR  405 – 415 Coiled-coil + - - 
 
low stoichiometry, with only a low level of ROCK1 co-immunoprecipitating with a 
relatively large amount of p120 (lane 2 and 3). Nonetheless, coupled with the mass 
spectrometry-based identification of ROCK1, these data suggest that ROCK1 physically 
associates with p120. 
The localization of endogenous ROCK1 was analyzed by immunofluorescence 
microscopy in A431 and MCF-7 epithelial cells (Figure 15a, upper row). Cells were 
plated on glass coverslips and stained with an anti-ROCK1 polyclonal antibody and anti-
p120 monoclonal antibody. In A431 cells ROCK1 co-localized precisely with p120 at 
cell-cell junctions and in cytoplasmic vesicle structures (arrows). In MCF-7 mammary  
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Figure 15: ROCK1 co-localizes with p120 at cell-cell junctions. (a) 
Immunofluorescence analysis of endogenous p120 and ROCK1 in A431 (upper panels) 
and MCF7 cells (lower panels). Arrowheads indicate co-localization of ROCK1 (red) 
with p120 (green) at cell-cell junctions. Arrows indicate co-localization of ROCK1 and 
p120 in cytoplasmic vesicles. (b) Immunofluorescence analysis of GFP alone or ROCK1-
GFP (green) and p120 (red) in A431 cells. Arrowheads indicate co-localization of GFP 
and p120 at cell-cell junctions. 
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adenocarcinoma cells (Figure 15a, lower row), ROCK1 also co-localized with p120 at 
cell-cell junctions. Interestingly, ROCK1 is primarily diffuse with limited cell-cell 
junction staining (arrow heads) in MCF-7 cells, making the association difficult to detect. 
Nonetheless, using ReCLIP and mass spectrometry I was able to detect an interaction 
between p120 and ROCK1 in MCF-7 cells (as reported in Appendix A). Thus, although 
the p120-ROCK1 association in MCF-7 cells is difficult to discern by traditional 
approaches (i.e. immunoprecipitation and immunofluorescence), it is readily detectable 
using ReCLIP. 
ROCK1 localization was further assessed using exogenous ROCK1 fused to GFP 
(ROCK1-GFP) (Figure 15b). A431 cells were transduced with GFP alone (LZRS neo 
GFP) or ROCK1-GFP (LZRS neo ROCK1-GFP) and analyzed by immunofluorescence 
for GFP and p120. ROCK1-GFP was primarily localized in the cytoplasm, however a 
distinct pool of ROCK1-GFP was localized to cell-cell junctions (arrow heads). In some 
cells, ROCK1-GFP co-localized with p120 in cytoplasmic vesicles (arrows), similar to 
endogenous ROCK1. In cells expressing GFP alone, GFP was localized diffusely 
throughout the cytoplasm and nucleus, but was not detectable cell-cell junctions. These 
data suggest that ROCK1 associates with p120 as part of the cadherin complex. 
  
ROCK1 is recruited to the cadherin complex 
A calcium switch assay was preformed to confirm that ROCK is associated with 
the cadherin complex. A431 cells were incubated in low calcium media (LCM) to deplete 
extracellular calcium levels and CaCl2 was added directly to the media to restore  
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Figure 16: ROCK1 is recruited to cell-cell junctions by cadherins. 
Immunofluorescence analysis of E-cadherin (green) and ROCK1 (red) A431 cells during 
a calcium switch assay. Cells were fixed and stained for the following conditions: (a) no 
calcium depletion (control), (b) depletion of calcium using low calcium media, (c) 10 
minutes post-calcium addback, (d) 30 minutes post calcium addback (white arrows 
indicate low levels of ROCK1 at cell junctions), (e) 60 minutes post-calcium addback, (f) 
60 minutes post calcium addback with incubation with E-cadherin and P-cadherin 
blocking antibodies (HECD-1 and 6A9). 
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physiological calcium levels (1.8 mM CaCl2) prior to immunofluorescence analysis for 
E-cadherin and ROCK1. As Figure 16 illustrates, depletion of extracellular calcium 
destabilized the adherens junction (b) and eliminated the pronounced cell-junction 
localization of ROCK1 observed under normal calcium levels (a). When cadherin 
contacts were initially established (i.e. the 10 minute time point, c), little to no ROCK1 
was localized to the nascent adherens junction. By 30 minutes post-calcium addback, 
ROCK1 began to concentrate at the maturing junction (d, arrows). By 60 minutes post-
calcium addback, ROCK1 was highly concentrated at cell junctions (e), similar to cells 
under normal calcium concentrations. ROCK1 recruitment correlated with the increased 
clustering of E-cadherin at cell-cell junctions (as assessed by E-cadherin staining). Thus 
it appears that ROCK1 recruitment does not occur during the initial stages of cell-cell 
adhesion, but rather during the clustering of cadherins following initial cell-cell contact 
as cadherins are engaged. Furthermore, inhibition of cadherin function using blocking 
antibodies against E-cadherin and P-cadherin prevented ROCK1 concentration at cell-cell 
contacts (f), confirming that this a cadherin-dependent event.  
 
ROCK1 physically interacts with E-cadherin in a p120-dependent manner 
To determine if ROCK1 is physically associated with the cadherin complex, 
crosslink-immunoprecipitation experiments were preformed in cadherin-negative A431D 
cells and A431D cells expressing either wild type or p120-uncoupled 764AAA E 
cadherin (Thoreson et al., 2000). Cells were pretreated with crosslinkers, lysed in RIPA 
buffer, and immunoprecipitations for p120 (Figure 17a lanes 2, 6, 10) , E-cadherin (lanes 
3, 7, 11) an irrelevant control antibody (IgG lanes 4, 8, 12) were carried out. Recovery  
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Figure 17: ROCK1 physically associates with the cadherin complex in a p120-
dependent manner. (a) Western blot analysis of lysates and p120, E-cadherin, or control 
immunoprecipitations from DSP-crosslinked A431D cells and A431D cells expressing 
wild type or 764AAA E-cadherin. (b) A model depicting p120-dependent association of 
ROCK1 with the cadherin complex, as detected by immunoprecipitation in (a).  
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of ROCK1, p120, and E-cadherin was assessed by western blot. ROCK1 co-
immunoprecipitated with wild-type E-cadherin (Figure 17a, top panel, lane 7), indicating  
that ROCK1 physically associates with the cadherin complex. However, ROCK1 did not 
co-immunoprecipitate with p120 uncoupled 764AAA E-cadherin (Figure 17a, top panel, 
lane 11), suggesting that p120 is required for ROCK1 to associate with the cadherin 
complex. Furthermore, ROCK1 was co-immunoprecipitated with p120 in the presence of 
wild-type E-cadherin, but not in the presence of 764AAA E-cadherin or in the total 
absence of cadherins (Figure 17a, top panel, compare lane 6 to lanes 2 and 10). This 
result is illustrated schematically in figure 17b.  
Immunofluorescence analysis of E-cadherin and ROCK in the A431D cells 
demonstrated that ROCK1 localized efficiently to adherens junctions in the presence of 
wild-type cadherin (Figure 18a, arrows). However, In the presence of 764AAA E-
cadherin, ROCK1 was significantly less abundant at cell junctions, relative to cells 
expressing wild-type E-cadherin (Figure 18a, b). These data suggest the presence of a 
complex consisting of E-cadherin, p120, and ROCK1 as part of the adherens junction. 
Importantly, ROCK1 is only physically associated with p120-bound E-cadherin.  
 
p120 associates with ROCK1 at the plasma membrane 
A p120 knockdown-reconstitution system (Davis et al., 2003) was used to assess 
the functional relationship between p120 and ROCK1 (Figure 19). Briefly, endogenous 
p120 was stably depleted using human-specific shRNA, and p120 was then reconstituted 
by expressing murine p120, which is unaffected by the shRNA. Endogenous ROCK1  
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Figure 18: ROCK1 localization in E-cadherin-reconstituted A431D cells. (a) 
Immunofluorescence analysis of E-cadherin (green) and ROCK1 (red) in A431D cells 
expressing wild type or 764AAA E-cadherin. White arrows indicate cell-cell contact 
localized ROCK1. (b) Quantification of cell-cell junction localization of ROCK1 
junction localization in A431D cells. Bars represent the average percentage of cells in 4 
20x fields with ROCK1 localized to cell-cell contacts. Error bars represent standard error 
of the mean.  
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Figure 19: p120 can regulate ROCK1 localization at cell-cell junctions. 
Immunofluorescence analysis of endogenous ROCK1 in wild type A431 cells (a), p120-
depleted A431 cells (hp120i) (b), or hp120i cells expressing (c) mp120 1A, (d) mp120 
3A, (e) mp120 4A, (f) mp120 3A arm1, (g) mp120 3A arm1 CAAX, or (h) mp120 1A 
622-8. (i) Quantification of ROCK1 localization at cell-cell contacts in the analyzed 
A431 cells lines. Bars represent the average percentage of cells in 4 20x fields with 
ROCK1 localized to cell-cell contacts. Error bars represent standard error of the mean.  
75 
localization was assessed by immunofluorescence in wild type A431 cells and p120-
depleted cells, and p120-reconstituted cells. Depletion of p120 leads to degradation of the  
cadherin complex and destabilization of cell-cell junctions. Consistent with this, ROCK1 
was lost from cell-cell contacts following p120 depletion (Figure 19b). p120 status did 
not affect ROCK1 protein expression levels as assessed by western blot (data not shown). 
Reconstitution of wild-type p120 efficiently restored cell-cell junctions and ROCK1 
localization at the cell junction (Figure 19c-e), regardless of the isoform (mp120 1A, 3A, 
or 4A) used for reconstitution. In contrast, addback of a mutant that does not bind to 
cadherins (mp120 3A arm1 Figure 19f) did not restore ROCK1 cell-junction 
localization. However, membrane targeting of the arm1 mutant using a C-terminal 
CAAX motif (Xia et al., 2006; Wildenberg et al., 2006) restored co-localization of p120 
and ROCK1 (Figure 19g), suggesting that these two proteins can interact in the absence 
of the cadherin complex. These data indicate that p120 can regulate ROCK1 localization 
to cell-cell contacts when it p120 is membrane associated (e.g. cadherin-bound). A Rho-
uncoupled p120 mutant (mp120 1A 622-8) (Anastasiadis et al., 2000) (Figure 19h) also 
co-localized with ROCK1 at cell-cell contacts. These data suggest that the association of 
ROCK1 with p120 is involved in the function and/or stabilization of the cadherin 
complex, rather than direct regulation of RhoA activity by p120.  
 
ROCK1 depletion affects the cadherin complex 
The functional relationship between ROCK1 and p120 was further assessed by 
shRNA-mediated depletion of ROCK1 in A431 cells (Figure 20). I was able to  
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Figure 20: Knockdown of ROCK1 affects cell-cell adhesion. (a) Western blot analysis 
of wild type A431 cells and A431 cells expressing Non-target or ROCK1 shRNA. (b) 
Quantification of ROCK1 levels as detected by western blot. Bars represent the relative 
ROCK1 levels normalized to tubulin, averaged from 3 experiments. Error bars represent 
standard error of the mean. (c-f) Immunofluorescence analysis of ROCK1 (red) and p120 
(c), E-cadherin (d), Ezrin (e), and F-actin (f) in wild type A431 cells and A431 cells 
expressing ROCK1 shRNA. Where applicable, ROCK1-knockdown cells are outlined in 
white. 
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achieve approximately 65% depletion of endogenous ROCK1 in A431 cells, with no 
change in ROCK2 levels as assessed by western blot (Figure 20a-b). Stable knockdown 
of ROCK1 did not affect the protein levels of p120 and E-cadherin. Immunofluorescence 
analysis indicated that knockdown of ROCK1 was mosaic, with a small population of 
cells expressing little to no ROCK1 (ROCK1-knockdown cells), and a larger population 
of cells expressing wild-type ROCK1 levels. ROCK1-knockdown cells were larger, 
suggesting reduced contractility in the absence of ROCK1. Strikingly, distribution of 
p120 and E-cadherin was dramatically altered in the ROCK1-knockdown cells, 
particularly at cell-cell junctions (Figure 20c and d, respectively). Based on p120 and E-
cadherin staining, cell-cell junctions were disorganized and weaker relative to cells with 
normal ROCK1 levels. The same effect was observed for -catenin, -catenin, 
Plakoglobin, and P-cadherin (Figure 21), suggesting that ROCK1 depletion affects the 
integrity of the entire cadherin complex. Membrane localization of Ezrin was also 
disrupted (Figure 20e), indicating that ROCK activity was deficient in ROCK1-
knockdown cells. Analysis of the actin cytoskeleton using phalloidin revealed that the 
junctional actin network of ROCK1i cells was disrupted (Figure 20f), which could 
account for the disruption of the cadherin complex. Similar results were observed in 
ROCK1 depleted MCF-7 cells depleted of ROCK1 (Figure 22).  
 To determine if the effects of ROCK1 depletion on the cadherin complex are the 
result of disruption of the acto-myosin pathway, I used chemical inhibitors to ablate 
ROCK and myosin II activity in wild type A431 cells and analyzed the cells by 
immunofluorescence (Figure 23). Wild-type A431 cells were serum starved and treated  
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Figure 21: ROCK1 depletion affects the entire cadherin complex. 
Immunofluorescence analysis of ROCK1 (red) and -catenin (a), -catenin (b), 
Plakoglobin (c), and P-cadherin (d) in wild type A431 cells and A431 cells expressing 
ROCK1 shRNA.
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Figure 22: ROCK1 depletion in MCF-7 cells affects p120 distribution. 
Immunofluorescence analysis of ROCK1 (red) and p120 (green) in MCF-7 cells 
expressing Non-Target shRNA or ROCK1 shRNA 
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Figure 23: Inhibition of ROCK and Myosin II activity mimic the effects of ROCK1 
depletion. Immunofluorescence analysis p120 (green) and ROCK1 (red) of vehicle 
treated wild-type A431 cells (a), A431 cells expressing ROCK1 shRNA (b), and wild  
type A431 cells treated with 10 μM Y-27632 (c) or 10 μM Blebbistatin (d) for 24 hours. 
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with DMSO vehicle alone (a), 10 μM Y-27632 (c), or 10 μM Blebbistatin (d) for 24 
hours, then processed for immunofluorescence analysis to detect p120 and ROCK1. For 
comparison, ROCK1 knockdown cells were serum starved and analyzed in parallel (b). 
Similar to ROCK1 depletion, Y-27632 and Blebbistatin resulted in large cells with 
disorganized adherens junctions, as assessed by p120 staining. Thus the effects of 
ROCK1 depletion are comparable to the effects of global ROCK inhibition. Furthermore, 
inhibition of myosin II produces the same phenotype of ROCK1 depletion. These results 
suggest that ROCK1’s role in the cadherin complex is to maintain the local acto-myosin 
network, thereby stabilizing cell-cell adhesion. 
 
ROCK1 phosphorylates p120 
 p120 has several serine/threonine phosphorylation sites, but few direct kinases 
that phosphorylate p120 are known. The ability of ROCK1 to phosphorylate p120 was 
tested using an in vitro kinase assay using immunoprecipitated p120 from A431 cells as a 
substrate for constitutively active ROCK1. p120 was immunoprecipitated from A431 
cells, and subsequently incubated with purified active ROCK1 (amino acids 17-535) in 
the presence of absence of 10 μM Y-27632. As Figure 24a shows, p120 is highly 
phosphorylated on Serine 268 (S268) and weakly phosphorylated on Threonine 916 
(T916), but not on any other residue assayed (serines 288 and 879, and threonine 310, b-
d). Phosphorylation of S268 does not occur in the presence of Y-27632 or in the absence 
of ATP (data not shown), indicating this is a ROCK-specific phosphorylation event.  
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Figure 24: ROCK1 can phosphorylate p120 in vitro. Western blot analysis of ROCK1 
kinase assays using immunoprecipitated p120 from A431 as a substrate for constitutively 
active ROCK1 in the presence or absence of Y-27632. Reactions were analyzed for total 
p120 (lower panels) and (a) pS268, (b) pS288, (c) pT310, (d) pS879, and (e) pT916. 
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Interestingly, p120 S268 does not match the reported ROCK consensus sequence 
of R/K-X-X-S/T, where “X” represents any amino acid (Riento and Ridley, 2003).  
Upstream sequence analysis reveals that S268 is within a highly conserved motif of R-V-
G-G-S, which resembles the classical ROCK consensus sequence with V265 representing 
an extra residue upstream of the two variable residues. This suggests that there may be 
more variability of ROCK1 substrates than originally described. 
 
Discussion 
 Modulation of the actin cytoskeleton by Rho GTPases plays an important role in 
cell-cell adhesion, however precise mechanisms remain unclear. In particular, the ROCK-
Myosin pathway has been implicated in this process (Shewan et al., 2005). While most 
reports discuss Rho kinases as a cytoplasmic proteins, ROCK1 has previously been 
detected at the cell membrane and at cell-cell contacts (Walsh et al., 2001; Nishimura and 
Takeichi, 2008), however the function of this pool of ROCK1, and how it associates with 
components of cell-cell junctions, have remained unclear. Here, I have demonstrated for 
the first time that p160 Rho Kinase, a major RhoA effector, physically associates with the 
cadherin complex through p120. 
Using a calcium switch assay, I have found that ROCK1 is recruited to nascent 
adherens junctions in a cadherin-dependent manner. ROCK1 recruitment occurs after the 
initial cadherin contacts are made, thus ROCK1 is not involved in the initial formation of 
the adherens junctions. Instead, ROCK1 is recruited at later time points, suggesting that 
ROCK1 is involved in the maintenance and/or maturation of the cadherin complex. The 
time-course of ROCK1 recruitment to the cadherin complex is consistent with 
84 
establishment of a junctional actin network (Zhang et al., 2005). This pool of junctional 
actin is not necessary for the establishment of cell-cell contacts, but is involved in the 
stabilization of clustered cadherins. Consistent with this, ROCK1 knockdown does not 
ablate cell-cell adhesion but does disrupt the normal organization of p120, E-cadherin, 
and F-actin at cell-cell junctions. These data suggest that ROCK1 is required for the 
maintenance of strong cell-cell adhesion in part through the modulation of a junction-
localized pool of F-actin. It is likely that additional ROCK1 targets are recruited to the 
cadherin complex at this later stage and contribute to cell-cell adhesion. ReCLIP analysis 
of E-cadherin complexes following initial cadherin engagement (i.e. 5 minutes post-
calcium addback) and during maturation of junctions (i.e. 30 minutes post-calcium 
addback) could identify proteins that participate in the ROCK1 cell-cell adhesion 
function.  
Importantly, the association of ROCK1 with the cadherin complex is dependent 
on p120, as a p120-uncoupled E-cadherin does not co-immunoprecipitate ROCK1. 
Immunofluorescence analysis of A431D cells illustrates a low level of ROCK1 can still 
localize to the cell membrane in the absence of cadherins or in the presence of the 
764AAA E-cadherin, which does not bind p120. However, although this pool of ROCK1 
is still membrane-bound, it can’t physically interact with cadherins without p120. p120-
dependent recruitment of ROCK1 to the cadherin complex may explain the altered 
cytoskeletal organization of cells expressing 764AAA E-cadherin (Thoreson et al., 2000). 
The mechanism that recruits ROCK1 to the membrane in these cells is unclear, 
but may be attributed to the C-terminal Pleckstrin Homology (PH) domain of ROCK1, 
which binds to lipids and targets proteins to cell membranes (Lemmon and Ferguson, 
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2000). Alternatively, ROCK1 may be recruited to the membrane by Shroom3 (Nishimura 
and Takeichi, 2008), which can recruit Rho Kinases to apical junctions. Additionally, it 
appears that p120 does not interact with ROCK1 unless it is recruited to the membrane by 
E-cadherin or another mechanism (i.e. use of a CAAX box). Taken together, these data 
indicate that p120 can recruit membrane-associated ROCK1 to the cadherin complex.  
 While this is the first report of a physical link interaction between ROCK1 and the 
cadherin complex, a functional relationship has been suggested in a number of studies. In 
some cases, ROCK1 can negatively regulate cell-cell adhesion, due largely to excess 
acto-myosin contractility (Wójciak-Stothard et al., 2001). While apparently contradictory 
to our results in A431 cells, these studies clearly support an important functional 
relationship between ROCK and the cadherin complex. It is likely that this relationship 
varies depending on cellular context. Importantly, most of these studies have relied on the 
expression of dominant-active/negative mutants and over-expression approaches, 
whereas I have found a physical interaction between p120 and ROCK1 under 
endogenous, physiological conditions. Excessive activation/inhibition of ROCK signaling 
in past studies may account for the differences between previous reports and our own 
results in A431 cells. 
 Our studies support several lines of evidence indicating a requirement for ROCK 
activity in cadherin function. Recent studies have indicated that acto-myosin contractility, 
downstream of ROCK1, is necessary for the establishment and maturation of adherens 
junctions (Shewan et al., 2005; Smutny et al., 2010). In these studies the ROCK appeared 
to be acting through a pool of junction-localized myosin IIA. Similarly, I observe that 
global inhibition of either ROCK with Y-27632 or of Myosin II with blebbistatin mimics 
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the effects of ROCK1 knockdown, leading to disorganized adherens junctions. By 
binding to p120, ROCK1 could act directly on the cadherin complex and/or the pool of 
myosin IIA localized at cell-cell junctions. Furthermore, a physical interaction with the 
cadherin complex would allow rapid, localized induction of contractility without 
affecting other cellular compartments. Additionally, ROCK1 can phosphorylate p120 in 
vitro, suggesting that ROCK1 may be acting directly on p120 in addition to activating 
myosin IIA at the adherens junction.  
 ROCK1 knockdown and inhibition of ROCK dramatically effects p120 
distribution in A431 and MCF-7 cells. Similarly, inhibition of Myosin IIA using either 
the myosin inhibitor blebbistatin or shRNA led to dramatic loss of E-cadherin in human 
embryonic stem cells due to downregulation of p120 (Li et al., 2010). A similar effect has 
been observed using the ROCK inhibitor Y-27632 (Harb et al., 2008). Interestingly, 
inhibition of ROCK activity promoted self-renewal of stem cells in the absence of cell-
cell adhesion and feeder fibroblasts. These data are consistent with our own work in 
A431 cells, as loss of ROCK1, which acts directly on Myosin II, also disrupts p120, 
although to a much lesser degree. Protein levels of p120 and E-cadherin are not affected 
by ROCK1 depletion, suggesting that the interaction of p120 and E-cadherin remains 
intact in these cells. In A431 cells, it appears p120 and the rest of the cadherin complex is 
mislocalized or modified rather than degraded. This may be due to differences in the 
model systems used in these studies. Li et al. used human embryonic stem cells, while 
our studies employed the A431 epidermoid carcinoma cell line. It is possible that p120 
and the cadherin complex may be more dependent on acto-myosin contractility in 
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pluripotent stem cells, as opposed to an immortalized cell line derived from fully 
differentiated tissue.  
 A functional relationship between p120 and RhoA, upstream of ROCK1, has been 
suggested by several earlier studies. In particular, it has been suggested that p120 can 
directly bind to RhoA and act as a Guanine Dissociation Inhibitor (GDI), thereby 
preventing RhoA activation (Anastasiadis et al., 2000; Castano et al., 2007; Yanagisawa 
et al., 2008). Our lab has previously demonstrated that p120 can associate with p190 
RhoGAP and recruit it to the cadherin complex, (Wildenberg et al., 2006), making p120 
and the cadherin complex an important point of regulation for RhoA. Here, I report that 
ROCK1, a major RhoA effector, associates with p120 at the adherens junction. Thus, in 
addition to suppressing RhoA through p190 RhoGAP and/or a GDI function, p120 can 
also recruit a major effector of RhoA, which would allow p120 to promote downstream 
signaling. Taken together, these data point to a dynamic RhoA complex within the 
adherens junction, with Rho effectors (ROCK1) and Rho suppressors (p190 RhoGAP and 
p120 itself) forming a functional unit. In this scenario, when contractility is needed at the 
adherens junction, ROCK1 is readily available to initiate signaling to Myosin II. Once the 
optimal levels of contractility are achieved, RhoA can be rapidly suppressed by p190 
RhoGAP and/or p120’s GDI function. Thus allowing rapid cycling of RhoA activity and 
downstream signaling at the cadherin complex.  
 In an in vitro kinase assay, I have found that ROCK1 can specifically 
phosphorylate p120 on serine 268. Modulation of p120 serine/threonine phosphorylation 
appears to be quite complex. Activation of PKC induces dephosphorylation of all known 
serine/threonine phosphorylation sites on the N-terminus of p120 (Xia et al., 2003) while 
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also inducing dramatic phosphorylation of S879 on the C-terminus (Brown et al., 2009). 
To date very few specific kinases and phosphatases that act directly on p120 have been 
identified. Identifying in vivo kinases has been difficult in part because S268, along with 
the majority of other serine/threonine sites, are basally phosphorylated. Further 
complicating our analysis, S268, along with the rest of the N-terminal serine/threonine 
phosphorylation sites appear to be dephosphorylated in response to Dominant Active 
RhoA expression (Xia et al., 2006). Thus under some conditions, Rho signaling may 
actually suppress S268 phosphorylation even through ROCK1 can directly phosphorylate 
this site. It should be noted however, that expression of dominant active Rho constructs 
has been known to introduce a number of artifacts in experimental systems (Boulter et al., 
2010). 
Recent work has shown that in SW480 cells, S268 and S269 can be 
phosphorylated by CK1 following Wnt stimulation (Casagolda et al., 2010). In A431 
cells, Wnt 3a and Wnt 5a cultured media did not modify S268 phosphorylation status 
(unpublished observations), suggesting that S268 is differentially modulated depending 
on cellular context. ROCK activation downstream of Wnt signaling is an attractive 
hypothesis, but other possibilities such as cadherin-based signaling must also be 
considered. Interestingly, S268 is highly phosphorylated in the presence of wild-type, but 
not p120-uncoupled 764AAA E-cadherin (Xia et al., 2006), and ROCK1 is physically 
associated with wild-type but not 764AAA E-cadherin. Thus cadherin binding and/or 
membrane association appears to play some role in S268 phosphorylation. The 
significance of S268 phosphorylation by ROCK1 remains unclear. A431 cells expressing 
S268 and S268/9 phospho-deficient and phospho-mimetic mutants are indistinguishable 
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from wild-type controls with respect to cell-cell adhesion (unpublished observations). 
Additional functional assays are necessary to determine if these mutants induce a 
measurable phenotype. Future experiments aimed at identifying the conditions under 
which ROCK1 phosphorylates p120 in cells should help clarify the function of this 
phosphorylation event.  
I have illustrated a novel physical and functional relationship between p120-
catenin and ROCK1. Importantly, p120 physically links ROCK1 to the cadherin 
complex. p120-dependent recruitment of ROCK1 to the cadherin complex may explain 
many recent findings regarding the role of acto-myosin contractility in cadherin function 
(Harb et al., 2008; Li et al., 2010; Smutny et al, 2010) and collective migration (Hidalgo-
Carcedo et al., 2011). Furthermore, p120 can be phosphorylated by ROCK1 on S268, 
suggesting that ROCK1 function at the cadherin complex involves phosphorylation of 
p120. I was unable to map the interaction between p120 and ROCK1 using a Yeast-2-
Hybrid approach, possibly due to an unknown phosphorylation event mediating the 
interaction. Future work focused on mapping this interaction and the generation of 
minimal uncoupling mutants will be necessary to determine more precisely how p120 and 
ROCK1 work together to co-ordinate acto-myosin contractility and cell-cell adhesion. 
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CHAPTER V 
 
FUTURE DIRECTIONS 
 
Introduction 
 In ReCLIP, I have developed a powerful tool to study labile protein complexes. 
Using this approach, I have identified several novel putative p120 binding partners. 
Among these, I have found that cd98 associates with p120 through E-cadherin, and 
ROCK1 associates with E-cadherin in a p120-dependent manner. Furthermore, I have 
demonstrated that p120 can be directly phosphorylated by ROCK1 on S268 in vitro, 
suggesting that this interaction may control p120 phosphorylation. While these findings 
have provided new insights into the function of p120 and the cadherin complex, a number 
of questions remain. Furthermore, the full potential of ReCLIP has yet to be explored. 
 
Generation of a p120 interactome  
 A particularly exciting application of ReCLIP is the development of a 
comprehensive p120 interactome. A functional interaction network could be generated by 
first determining the binding partners of p120 and then reiterating the process on p120’s 
direct binding partners. Proteins that are commonly detected across all the samples could 
be included the functional network. For example, E-cadherin and -catenin ReCLIP 
eluates could be analyzed along side p120 eluates, common proteins in each sample could 
be incorporated into a protein interaction network for the cadherin complex. The cadherin 
interaction network could then be expanded by performing ReCLIP using some of these 
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common proteins as bait. Similarly, p120 eluates could be compared to eluates from 
Kaiso pull-downs to provide further insight into the functional significance of the p120-
Kaiso interaction. The generation of such extensive interaction maps would require 
considerable effort and optimization, but would provide a large number of new functional 
insights into the function and regulation p120 and it’s associated complexes. 
Furthermore, such studies were not feasible using prior to the development of ReCLIP.  
 
Identification of cytoplasmic and nuclear p120 binding partners 
 To date, p120 ReCLIP studies have been preformed exclusively in epithelial cell 
lines. In epithelial cells, it has been suggested that the vast majority of the total cellular 
p120 is present at the membrane, bound to E-cadherin (Kiss et al., 2008). Thus the 
binding partners detected in these experiments most likely represent cadherin-based 
functions of p120, as appears to be the case with ROCK1. Furthermore, the large 
abundance of cadherin-bound p120 may mask any cadherin-independent p120 binding 
partners in mass spectrometry analysis. As a result, the currently reported ReCLIP 
experiments do not provide a complete picture of p120 binding partners. Cytoplasmic 
p120 complexes are under-represented in MS analysis relative to the highly abundant 
cadherin-based complexes and nuclear complexes are lost due to inefficient recovery of 
nuclear proteins using standard lysis methods.  
 Determining the binding partners of cytoplasmic p120 is particularly interesting 
because the transition to metastasis is often associated with increased cytoplasmic 
localization of p120 (Sarrio et al., 2004). One approach to study cytoplasmic p120 is to 
perform ReCLIP using a cell line that lacks classical cadherins, such as the A431D or 
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MDA-MD-231 cell lines. In these cells, endogenous p120 is mostly cytoplasmic due to 
the lack of cadherins. In this context, any proteins identified would represent candidate 
binding partners for cytoplasmic p120. Furthermore, wild-type E-cadherin can be 
exogenously expressed in these cells to recruit p120 to the membrane, away from 
cytoplasmic binding partners. This could provide a useful experimental control, as real 
cytoplasmic p120 binding partners would not be detected in ReCLIP samples from cells 
expressing exogenous E-cadherin. A potential drawback of this approach is that the 
abnormally high levels of cytoplasmic p120 in these cells may lead to non-physiological 
interactions. Nonetheless, cadherin-negative cell lines should provide a good starting 
point, since the established experimental procedures should require little alteration in 
these systems. 
 Most standard lysis conditions do not efficiently recover nuclear proteins, thus 
nuclear p120 binding partners would likely be lost even in cadherin-negative cells. To 
overcome this issue, subcellular fractionation could be carried out following crosslinking, 
so the cytosolic and nuclear p120 complexes can be purified in isolation from each other. 
Furthermore, subcellular fractionation could be carried out using epithelial cell lines such 
as A431 or MCF-7 cells rather than cadherin-negative cell lines. Regardless of the cell 
line used, the starting material will likely have to be scaled up considerably to account for 
the low abundance of nuclear p120, and crosslinking conditions may need to be further 
optimized to ensure nuclear protein complexes are efficiently crosslinked.  
 
Structure-Function Analysis of the p120-ROCK1 Interaction 
 Although I have shown that ROCK1 and p120 co-immunoprecipitate, and that 
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ROCK1 associates with E-cadherin in a p120-dependent manner, I have been unable to 
determine if p120 and ROCK1 directly interact with each other. Future experiments are 
aimed at determining this as well as mapping the reciprocal binding sites between p120 
and ROCK1.  A potential approach is to use purified protein fragments fused to either 
Maltose Binding Protein (MBP) and Glutathione-S-Transferase (GST) for in vitro 
binding assays. Distinct binding sites can then be mapped using site-directed mutagenesis 
to determine the specific amino acids required for the interaction.  
 If a direct interaction between p120 and ROCK1 can be identified and mapped, 
then minimal uncoupling mutants can be generated. Such mutants would uncouple p120 
from ROCK1 without affecting its other binding partners, and vice-versa. Expression of 
these mutants in cells could help identify the specific function of the p120-ROCK1 
interaction. For example, do the cell-cell adhesion functions of ROCK1 require the 
interaction with p120? Does expression of p120-uncoupled ROCK1 rescue the effects of 
ROCK1 knockdown or ROCK inhibition? Furthermore, does expression of a ROCK1-
uncoupled p120 mimic ROCK inhibition with respect to the cell-cell adhesion? 
Generation of minimal uncoupling mutants should allow these questions to be answered 
in vivo.  
 
Physiological mechanisms of ROCK1-dependent p120 phosphorylation 
 Using an in vitro kinase assay with a constitutively active ROCK1 fragment, I have 
demonstrated that ROCK1 can phosphorylate p120 on serine 268. However, the 
physiological mechanism by which ROCK1 phosphorylates p120 remains unknown. A 
recent report indicates that Wnt stimulation can induce S268 phosphorylation and this is 
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required for Wnt signaling (Casagolda et al., 2010). In A431 cells, Wnt 3a and 5a 
cultured media does not affect S268 phosphorylation, suggesting that this pathway may 
not be intact in all cell-types. 
 One approach to identify stimuli that phosphorylate p120 in a ROCK-dependant 
manner is to use an In-Cell Western (ICW) assay to simultaneously screen multiple 
agonists in the presence and absence of the ROCK inhibitor Y-27632. This assay has 
previously been used to evaluate phosphorylation of p120 on S879. The 96-well format 
of the ICW assay should significantly accelerate the process of screening agonists. One 
appealing hypothesis is that S268 is phosphorylated by ROCK1 in response to cadherin 
engagement and clustering. Our calcium switch experiments indicate that ROCK1 is 
recruited to the newly established adherens junctions, and A431-D and p120-addback 
experiments suggest p120 only associates with ROCK1 when it is localized to the 
cadherin complex or the cell membrane. Furthermore, serine 268 is highly 
phosphorylated when it is cadherin or membrane-associated (Xia et al., 2006). 
Preliminary experiments using calcium switch and antibody-mediated cadherin clustering 
assays (Betson et al., 2002) should provide important clues as to whether cadherin 
clustering involves ROCK1-mediated phosphorylation of p120.  
 
Functional Significance of S268 Phosphorylation 
 Although I have found that ROCK1 depletion or inhibition effects p120 and the 
cadherin complex, I have not been able to identify a specific function for S268 
phosphorylation. Previous studies indicate that S268 phosphorylation is not required for 
cadherin stability (Xia et al., 2006). Furthermore, mutation of all serine/threonine 
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phosphorylation sites to alanine appears to have no effect on cadherin stability. Thus, it is 
unlikely that p120 phosphorylation is essential to cadherin engagement and clustering. 
 If S268 phosphorylation is ROCK1-dependent, then assays based on ROCK1 
function rather than p120 function may prove more fruitful. For example, is S268 
phosphorylation involved in the ability of ROCK to regulate cell migration (Worthylake 
et al., 2001)? Additionally, the pS268 mAb and ReCLIP could be used to identify binding 
partners that are specific to serine-268 phosphorylated p120. Novel binding partners or 
complexes identified in these experiments could provide insight into the function of S268 
phosphorylation, and help direct future functional experiments.  
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CHAPTER VI 
 
CONCLUDING REMARKS 
 
 This work has generated an important new tool to facilitate the study of p120 and 
the cadherin complex. ReCLIP has been optimized for the cadherin complex and has 
proven highly effective for these studies, but the method is also applicable to other 
targets, provided the necessary optimizations (i.e. crosslinker concentrations and 
treatment times, antibody concentrations) are carried out prior to large scale experiments. 
Every protein and complex is different, thus different conditions may be required for 
different targets. In order to fully exploit the potential of ReCLIP, more in depth studies 
will be necessary to determine the limitations of the method. In particular, the efficiency 
of ReCLIP to study over-expressed proteins has yet to be determined. Nonetheless, we 
anticipate that ReCLIP could become a widely used approach for mass spectrometry-
based protein interaction studies. Indeed, it has already been used by a number of 
researchers throughout Vanderbilt University. 
 Using ReCLIP, we have overcome a significant problem in the p120 field, 
specifically the labile nature of p120 interactions. Our initial attempts using a TAP-tag 
method proved unsuccessful, with efficient recovery of p120 itself but few binding 
partners detected, including the cadherin complex. With ReCLIP, however, I not only 
dramatically improved cadherin complex recovery over previous attempts, but also 
identified several putative p120 binding partners in a clean single affinity-purification 
approach.  Future experiments aimed at studying p120 interactions under a variety of 
97 
conditions should provide even further insight into p120 function. Thus ReCLIP will 
facilitate more sophisticated and comprehensive p120 studies than we have been able to 
do in the past. 
 With the identification of ROCK1 as a p120 binding partner, I have shed new 
light onto the function and regulation of the actin cytoskeleton at the cadherin complex. It 
is clear that that the cadherin complex is far more than a structural module, and plays an 
active role in coordinating adhesion, motility, and cell growth. ROCK1 almost certainly 
fits into this role, given the variety of its substrates and the diversity of its own cellular 
functions. Importantly, the p120-dependent recruitment of ROCK1 to the cadherin 
complex suggests that p120 can play a role in potentiating Rho signaling, as well as 
suppressing Rho signaling as has been previously reported. This adds a new layer of 
complexity to the functions of p120 with regards to both cadherin stabilization and Rho 
regulation. The full significance of this work remains to be determined, but we are in a 
good position to elucidate both broad p120 functions and the evolving relationship 
between p120 and the Rho/ROCK/acto-myosin pathway. 
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APPENDIX A 
 
ADDITIONAL APPLICATIONS OF RECLIP TO IDENTIFY  
P120 BINDING PARTNERS  
 
Introduction 
 As illustrated in chapter three, I have developed a highly efficient method for 
isolating and identifying p120 binding partners. Using ReCLIP, I identified several novel 
candidate p120 binding partners in A431 cells under standard growth conditions. Because 
ReCLIP uses a monoclonal antibody to recover target complexes, this approach affords a 
great deal of versatility. For example, it is possible to efficiently compare endogenous 
binding partners across multiple cell types (i.e. breast, colon, fibroblast cells) to identify 
tissue-specific binding partners and potential functions. In addition, complexes can be 
studied in the presence and absence of specific stimuli that induce p120 phosphorylation. 
Signaling through p120 likely involves the transient recruitment of protein to p120 in 
response to phosphorylation.  Utilizing ReCLIP, phospho-specific complexes can be 
immunoprecipitated with phospho-specific mAb beads and analyzed by mass 
spectroscopy. This approach could not only identify the kinases and phosphatases that 
directly modify p120, but also identify downstream functional interactions that may be 
too weak or transient to detect without cross-linking. 
 The preliminary studies described here represent an initial attempt to exploit 
ReCLIP in the above manner. While the results are not conclusive, they do provide a 
good starting point for future comprehensive studies of p120 binding partners across 
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multiple cell lines and conditions that could yield more valuable results. Furthermore, 
these preliminary studies highlight important considerations that should be included in 
the planning of future ReCLIP experiments. 
 
Results 
 
Comparison of ReCLIP results across epithelial cell lines 
 To determine if variability between cell lines affects ReCLIP efficacy, I 
performed ReCLIP in A431 epidermoid carcinoma cells, MCF-7 mammary 
adenocarcinoma cells, MCF-10A non-transformed mammary epithelial cells, Caco-2 
colorectal adenocarcinoma cells, and HCA-7 colonic adenocarcinoma cells. Crosslinking 
in all cell lines was carried out using the DSP and DTME combination. p120 was 
immunoprecipitated with mAb 15D2, while mAb 8D11 was used as a negative control. 
Western blot analysis of 10% of each eluate confirmed that ReCLIP successfully 
recovered E-cadherin in all cell lines using mAb 15D2, but not 8D11 (Figure 25). HCA-7 
cells express very low levels of p120 and E-cadherin, thus the recovery of E-cadherin 
was not detectable in the fraction of eluate analyzed by western blot. However, 
subsequent MS analysis shows that a small amount of E-cadherin and associated catenins 
were recovered (Table 5). 
Following western blot analysis, the remaining ReCLIP eluates were analyzed by 
single dimension LC-MS/MS. Background was comparable across all cell lines, and only 
proteins with 0 spectral counts detected in control eluates were considered valid  
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Figure 25: E-cadherin recovery in ReCLIP eluates from epithelial cell lines. Western 
blot analysis of E-cadherin in whole cell lysates, p120, and control IgG ReCLIP eluates 
from A431, MCF-7, MCF-10A, Caco-2, and HCA-7 cells. Due to the number of samples, 
two separate blots were used. 
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candidates. Proteins identified across 2 or more cell lines are listed in table 5. As Table 5 
shows, the core components of the cadherin complex were recovered across all cell lines, 
with particularly robust recovery from MCF-7 cells. A comparison of proteins detected in 
2 or more cell lines showed that several candidate binding partners previously recovered 
from A431 cells were also recovered from the other cell lines tested including ROCK1, 
cd98, VDP, and vinculin. In this particular preliminary experiment, ROCK1 and vinculin 
were not detected in A431 cells, but were detected in other cell lines. Furthermore, the 
polarity protein scribble was recovered exclusively in the breast epithelial cell lines 
(MCF-7 and MCF-10A). These preliminary results indicate that the efficacy of ReCLIP 
is consistent across multiple epithelial cell lines. Furthermore, these results show some  
Table 5: Common proteins detected across multiple cell lines by ReCLIP. Total 
spectral counts detected for each indicated protein from p120 ReCLIP eluates. For all 
proteins listed, zero peptides were detected in control samples.  
 
Protein 
UniProt 
Accession A431 MCF7 
MCF 
10A Caco-2 HCA-7 
cd98 (4F2 Heavy Chain) IPI00027493.1 6 4 0 7 0 
E-cadherin IPI00000513.1 6 12 12 10 4 
alpha1-catenin IPI00215948.4 15 30 22 18 8 
beta1-catenin IPI00017292.1 16 22 20 17 3 
Junction Plakoglobin IPI00554711.2 14 20 9 19 4 
TAP/VDP/p115  IPI00031583.4 5 2 7 4 4 
ROCK1  IPI00022542.1 0 10 12 4 0 
Isoform 1 of L-lactate 
dehydrogenase A chain 
IPI00217966.7 
0 2 0 2 3 
Scribble (Isoform 3 of 
Protein LAP4) 
IPI00410666.1 
0 3 2 0 0 
Na/K-transporting ATPase 
subunit -1 
IPI00006482.1 
4 3 0 5 0 
Na/K-transporting ATPase 
subunit a-2 
IPI00003021.1 
3 3 0 3 0 
Isoform 1 of Vinculin IPI00291175.7 0 0 5 5 3 
EpCAM (Tumor-
associated calcium signal 
transducer 1) 
IPI00296215.1 
0 3 2 2 0 
Transferrin receptor 
protein 1 
IPI00022462.2 
0 2 2 0 0 
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complexes may associate with p120 more prevalently in some cell types (i.e. scribble in 
mammary epithelial cells), underscoring the importance of testing multiple cell lines in 
binding partner studies.  
 
Identification of binding partners in PMA stimulated cells 
 Prior to ReCLIP analysis of phosphorylated p120, it was necessary to determine if 
in-cell crosslinking could affect p120 phosphorylation status. A431 cells were serum 
starved and treated with vehicle or PMA for 30 minutes to activate PKC signaling and 
induce phosphorylation on p120 S879. Following PMA treatment, in-cell crosslinking 
was carried out using DMSO vehicle or the DSP and DTME combination as described 
previously. Whole cell lysates were then analyzed by western blot to assess p120 S879 
phosphorylation. As Figure 26a illustrates, PMA treatment induces robust 
phosphorylation of S879 in both the presence and absence of crosslinker. These data 
suggest that p120 phosphorylation is not affected by the crosslinking process.  
 The MCF-7 cell line was selected for large-scale ReCLIP analysis of p120 
binding partners in PMA-stimulated cells, due to the improved binding partner recovery I 
observed in previous experiments. I confirmed that similar to A431 cells, p120 
phosphorylation status in MCF-7 cells was unaffected by crosslinking (data not shown). 
MCF-7 cells were serum starved overnight, and treated with either vehicle alone or PMA 
for 30 minutes, then processed for ReCLIP analysis the DSP and DTME combination 
crosslinking condition. Immunoprecipitations were carried out using mAb 15D2 for total 
p120, anti-phospho-S879 mAb for phosphorylated p120 alone, or mAb 8D11 as a 
negative control. Western blot analysis of ReCLIP eluates demonstrates that E-cadherin  
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Figure 26: Application of ReCLIP to study p120 phosphorylation. (a) Western blot 
analysis of phospho-S879 (pS879) and total p120 in A431 cells in the presence of 
absence of PMA and crosslinkers (DSP and DTME combined). (b) Western blot analysis 
of E-cadherin whole cell lysates and p120, pS879, and control IgG ReCLIP eluates from 
serum starved and PMA-treated MCF-7 cells. 
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is efficiently recovered in 15D2 immunoprecipitations from both serum starved and PMA 
treated cells (Figure 26b). Using the S879 mAb, E-cadherin was only recovered from 
PMA-treated cells, consistent with phosphorylation of S879 in response to PMA. ReCLIP 
samples were analyzed by single dimension LC-MS/MS to identify putative binding 
partners. As expected, the core components of the cadherin complex were recovered 
efficiently using mAb 15D2 under both serum starvation and PMA conditions (Table 6). 
In addition, multiple binding partners previously identified in other cell lines were 
detected including cd98, VDP, GOLGA4, ROCK1, and Scribble. In addition, p190 
RhoGAP was identified in 15D2 ReCLIP eluates, consistent with our earlier studies 
(Wildenberg et al., 2006). Using the anti-pS879 mAb, the cadherin complex was 
recovered under both serum starvation, consistent with the low level of basal S879 
phosphorylation observed in western blot analysis. Under PMA treated conditions, 
recovery of E-cadherin was more efficient in PMA treated cells as assessed by spectral 
counts.  
In addition to the cadherin complex, pS879 ReCLIP also captured Kinesin Heavy 
Chain (KHC), which has been previously identified as a p120 binding partner (Chen et 
al., 2003). Surprisingly, these eluates also contained snd1, a component of the RNA-
Induced Silencing Complex (RISC) that is up-regulated in colon carcinogenesis and may 
regulate E-cadherin and APC (Tsuchiya et al., 2007). Recovery of both KHC and snd1 
were equivalent between serum starved and PMA treated cells, as assessed by spectral 
counts, unlike the cadherin complex. Furthermore neither protein was detected in 15D2 
eluates It is possible that KHC and snd1 are basally associated with p120, but cannot be 
recovered by 15D2 due to epitope masking.  
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Table 6: Proteins identified in serum starved and PMA-treated MCF-7 cells. Total 
spectral counts for the identified proteins identified in 15D2 and pS879 ReCLIP samples 
from serum starved of PMA-stimulated cells. No peptides of the indicated proteins were 
detected in control samples. 
 
               Serum Starved            PMA  
Protein 
UniProt 
Accession 15D2 pS879 15D2 pS879 
cd98 (4F2 heavy chain) IPI00027493.1 7 3 5 13 
E-cadherin IPI00000513.1 16 5 10 21 
alpha1-catenin IPI00215948.4 38 18 26 56 
beta1-catenin IPI00017292.1 23 18 15 36 
Junction Plakoglobin IPI00554711.2 22 11 21 32 
52 kDa Ro protein (TRIM21) IPI00018971.7 20 29 13 28 
TAP/VDP/p115  IPI00031583.4 10 0 11 0 
ROCK1  IPI00022542.1 46 0 32 0 
GOLGA4 (Isoform 1 of Golgin 
Subfamily A member 4) 
IPI00013272.1 
54 0 34 0 
Epiplakin IPI00010951.2 5 0 3 0 
Scribble (Isoform 3 of Protein LAP4) IPI00410666.1 4 0 0 4 
Isoform 3 of Septin-9 IPI00455033.5 2 4 3 5 
Septin-2 IPI00014177 2 3 0 5 
Septin-11 IPI00019376.6 0 5 0 4 
Isoform 1 of Rho GEF 7 IPI00449906.3 3 0 2 0 
Rab GDP dissociation inhibitor beta IPI00031461.1 2 0 0 3 
Ras-related protein Rab-11B IPI00020436.4 0 0 0 2 
p190 RhoGAP (Isoform 1 of 
Glucocorticoid receptor DNA-binding 
factor 1) 
IPI00334715.3 
6 0 9 0 
Kinesin heavy chain IPI00012837.1 0 3 0 2 
Snd1 (staphylococcal nuclease and tudor 
domain containing 1) 
IPI00140420.4 
0 18 0 12 
adaptor-related protein complex 2, beta 
1 subunit 
IPI00784156 
3 2 2 0 
adaptor-related protein complex 1, 
gamma 1 subunit isoform 
IPI00293396.5 
3 0 2 0 
Coatomer subunit alpha IPI00295857.6 5 0 3 0 
Isoform 2 of Coiled-coil domain-
containing protein C6orf97 
IPI00216412.8 
0 9 0 3 
Sodium/potassium-transporting ATPase 
subunit -2  
IPI00003021.1 
0 0 0 2 
Sodium/potassium-transporting ATPase 
subunit -1 
IPI00006482.1 
0 0 2 4 
Myosin-9 IPI00019502.3 0 0 0 2 
Myosin-Ic IPI00010418.4 0 0 0 3 
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Discussion 
Chapter three described the extensive optimization and validation of ReCLIP in 
A431 cells under standard growth conditions. To exploit the potential of ReCLIP, I 
sought to characterize p120 binding partners in a wider range of cell types and 
conditions. The experiments described here are only preliminary, but do provide evidence 
of the efficacy of ReCLIP across multiple cell-types and conditions and highlight 
important considerations for future applications of ReCLIP. The methodology described 
here should facilitate more comprehensive studies to identify binding partners via 
ReCLIP.  
 ReCLIP results across multiple human epithelial cell lines were remarkably 
consistent with respect to the cadherin complex. The core components of the cadherin 
complex (E-cadherin and -catenin, -catenin, and Plakoglobin) were all efficiently 
recovered with similar spectral counts across four of the five cell lines tested. Recovery 
was less robust in HCA-7 cells, as this cell line expresses less p120 and E-cadherin as 
indicated in western blot experiments. The recovery of candidate binding partners such as 
cd98 and ROCK1 in other cell lines besides A431 cells provides further support for the 
significance of these interactions. Interestingly, the polarity protein scribble was 
detectable in mammary epithelial cell lines (MCF-7 and MCF-10A), but not in other cell 
lines. This suggests that the components of p120 complexes may vary between different 
tissue types, and highlights the value of screening multiple cell lines in binding partner 
studies. If only one cell line is studied, it is likely that a number of important interactions 
would be missed because they may not be prevalent in the specific cell line used. A 
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comprehensive ReCLIP screen of cell lines covering multiple tissue types would be 
extremely informative and provide a broader view of p120 complexes and functions. 
 Because ReCLIP has been optimized for use with monoclonal antibodies, 
phospho-specific antibodies can be used with ReCLIP to specifically study binding 
partners associated with the phosphorylated form of a target protein. To that end, I 
performed ReCLIP in PMA-stimulated or unstimulated (serum starved) cells using both a 
total p120 (15D2) and a phospho-S879 mAb for immunoprecipitation. The physiological 
significance of PKC-mediated phosphorylation of S879, and dephosphorylation of the N-
terminus remains unknown, despite extensive study (Xia et al., 2006, Brown et al., 2009). 
Unfortunately, aside from the cadherin complex no change in binding partner recovery 
with the pS879 mAb was observed following PMA treatment. It is possible that any 
phospho-specific transient binding partners had already dissociated from p120 by the 30 
minute treatment time-point at which crosslinking was initiated, as this represents the 
peak of p120 phosphorylation following PMA treatment. Crosslinking at earlier time-
points may capture transient interactions before they dissociate. Thus, preliminary time-
course experiments should be carried out to determine the shortest treatment time at 
which crosslinking can be initiated to minimize the loss of transient binding partners. 
Interestingly, some binding partners that were recovered abundantly using mAb 
15D2, such as ROCK1 and GOLGA4, were not recovered at all using the pS879 mAb, 
suggesting that these proteins may not associate with p120 when S879 is phosphorylated. 
It is possible that differential localization of phosphorylated versus unphosphorylated 
p120 may explain this (e.g. p120 may not be phosphorylated when associated with 
GOLGA4 in the Golgi Apparatus). Alternatively, these protein complexes may mask the 
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pS879 epitope, such that only p120 that is not associated with these complexes is 
recovered by the pS879 mAb. Similarly, KHC and snd1 were detected in pS879 but not 
15D2 eluates. Thus it is clear that different monoclonal antibodies can recover unique 
sets of binding partners. It would be particularly interesting to compare ReCLIP results 
using multiple p120 monoclonal antibodies, as this experiment could reveal novel 
binding partners that are not detectable using 15D2 alone.  
 Taken together, these experiments indicate that ReCLIP is effective across 
multiple cell types and conditions. However, the differences between recovered proteins 
across the different cell lines highlights the importance of evaluating multiple cell lines 
prior to more complex ReCLIP experiments. While PMA-treatment did not yield any 
phospho-specific novel binding partners in our experiments, further optimization of 
treatment times and crosslinking conditions may yield novel phospho-specific transient 
binding partners that could not be captured at the 30 minute time-point used here. Similar 
experiments could be carried out using different combinations of stimuli and phospho-
specific p120 mAbs. Alternatively, total p120 could be isolated from a cell line treated 
with a panel of stimulants (EGF, PMA, LPA, Wnt 3a, etc) to identify changes in p120 
complexes under each condition. However, each condition will require optimization to 
determine the minimal treatment time prior to carrying out large-scale ReCLIP 
experiments.  
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